UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 14A
                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION
                  Proxy Statement Pursuant to Section 14(a) of
            the Securities Exchange Act of 1934 (Amendment No.      )

Filed by the Registrant   X

Filed by a Party other than the Registrant

Check the appropriate box:

 X  Preliminary Proxy Statement

   Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))

   Definitive Proxy Statement

   Definitive Additional Materials

   Soliciting Material Pursuant to Sec.240.14a-12


                        N-VIRO INTERNATIONAL CORPORATION

--------------------------------------------------------------------------------

                (Name of Registrant as Specified In Its Charter)




--------------------------------------------------------------------------------

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)



Payment of Filing Fee (Check the appropriate box):

 X  No fee required.

   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)     Title of each class of securities to which transaction applies:

--------------------------------------------------------------------------------




(2)  Aggregate number of securities to which transaction applies:

--------------------------------------------------------------------------------




(3)  Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):

--------------------------------------------------------------------------------




(4)   Proposed maximum aggregate value of transaction:

--------------------------------------------------------------------------------




(5)  Total fee paid:

--------------------------------------------------------------------------------




  Fee paid previously with preliminary materials.

Check  box  if  any  part  of the fee is offset as provided by Exchange Act Rule
0-11(a)(2)  and  identify  the  filing  for  which  the  offsetting fee was paid
previously.  Identify  the  previous filing by registration statement number, or
the  Form  or  Schedule  and  the  date  of  its  filing.

(1)  Amount Previously Paid:

--------------------------------------------------------------------------------




(2) Form, Schedule or Registration Statement No.:

--------------------------------------------------------------------------------




(3) Filing Party:

--------------------------------------------------------------------------------




(4) Date Filed:

--------------------------------------------------------------------------------








July     , 2009
To all Our Stockholders:

     The  Board  of Directors cordially invites you to attend our Annual Meeting
of  Stockholders.  The  meeting  will  be  held at Brandywine Country Club, 6904
Salisbury  Road, Maumee, Ohio, 43537, on August 5, 2009.  The meeting will begin
at  3:00  p.m.  (local  time),  and  registration  will  begin  at  2:30  p.m.
Refreshments  will  be  served  before  the  meeting.

     In  addition  to  the matters described in the attached Proxy Statement, we
will  report  on  our business and progress during 2008 and the first quarter of
2009.  Our  performance for the year ended December 31, 2008 is discussed in the
enclosed  2008  Annual  Report  to  Stockholders.

     We  hope  you will be able to attend the meeting and look forward to seeing
you  there.

                         Sincerely,

                         /s/   Timothy  R.  Kasmoch
                         --------------------------
                         Timothy  R.  Kasmoch
                         President  and  Chief  Executive  Officer






                       N-VIRO INTERNATIONAL CORPORATION
                       3450 W. Central Avenue, Suite 328
                               Toledo, Ohio 43606

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
                          TO BE HELD ON AUGUST 5, 2009

TO  OUR  STOCKHOLDERS:

     NOTICE IS HEREBY GIVEN that our Annual Meeting of Stockholders will be held
at  Brandywine Country Club, 6904 Salisbury Road, Maumee, Ohio, 43537, on August
5,  2009.  The  Annual  Meeting  will  begin  at 3:00 p.m. (local time), for the
following  purposes:

1.     To  elect  four  Class  I  Directors for a term of two years, until their
successors are elected and qualified or until their earlier resignation, removal
from  office  or  death.

2.     To adopt an amendment to our Amended and Restated 2004 Stock Option Plan
to increase the number of shares available under the plan.

3.     To approve an amendment to our Second Amended and Restated Certificate of
Incorporation to increase the authorized shares of Common Stock.

4.     To ratify the appointment of UHY LLP to serve as our independent auditors
for our year ended 2009.

5.     To  transact  such other business as may properly come before the meeting
or  any  adjournment  thereof.

     Your  attention is directed to the Proxy Statement accompanying this Notice
for  a  more  complete description of the matters to be acted upon at the Annual
Meeting.  Our 2008 Annual Report is also enclosed.  Stockholders of record as of
the  close  of  business  on June 10, 2009 will be entitled to notice of, and to
vote  at,  the  Annual  Meeting  or  any  adjournment  thereof.

                              BY  ORDER  OF  THE  BOARD  OF  DIRECTORS


                              /s/  James  K.  McHugh
                              ----------------------
                              James  K.  McHugh
                              Chief  Financial  Officer, Secretary and Treasurer

Toledo,  Ohio
July _, 2009

YOUR  VOTE  IS IMPORTANT. PLEASE COMPLETE AND SIGN THE ENCLOSED PROXY AND RETURN
IT  PROMPTLY  IN  THE  ENVELOPE  PROVIDED  WHETHER OR NOT YOU PLAN TO ATTEND THE
ANNUAL  MEETING  TO ASSURE THE PRESENCE OF A QUORUM. THE PROXY MAY BE REVOKED BY
YOU  AT  ANY  TIME,  AND GIVING YOUR PROXY WILL NOT AFFECT YOUR RIGHT TO VOTE IN
PERSON  IF  YOU ATTEND THE ANNUAL MEETING. YOU ALSO MAY VOTE YOUR SHARES VIA THE
TELEPHONE  BY ACCESSING THE TOLL-FREE NUMBER INDICATED ON YOUR PROXY CARD OR VIA
THE  INTERNET  BY  ACCESSING THE WORLDWIDE WEBSITE INDICATED ON YOUR PROXY CARD.




                        N-VIRO INTERNATIONAL CORPORATION
                       3450 W. CENTRAL AVENUE, SUITE 328
                               TOLEDO, OHIO 43606

               PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS
                          TO BE HELD ON AUGUST 5, 2009


SOLICITATION OF PROXIES AND DATE, TIME AND PLACE OF ANNUAL MEETING

     THIS  PROXY  STATEMENT  IS  FIRST  BEING SENT TO THE STOCKHOLDERS OF N-VIRO
INTERNATIONAL  CORPORATION  (THE  "COMPANY")  ON  OR  ABOUT  JULY  __,  2009, IN
CONNECTION  WITH  THE  SOLICITATION  OF  PROXIES BY OUR BOARD OF DIRECTORS TO BE
VOTED  AT  OUR  ANNUAL  MEETING OF STOCKHOLDERS (THE "ANNUAL MEETING"), WHICH IS
SCHEDULED  TO  BE HELD ON WEDNESDAY, AUGUST 5, 2009 AT 3:00 P.M. (LOCAL TIME) AS
SET  FORTH  IN  THE  ATTACHED  NOTICE.  A  PROXY  CARD  IS  ENCLOSED.

RECORD  DATE

     The record date for our Annual Meeting is the close of business on June 10,
2009.  Only  holders  of  record  of  our  Common  Stock  on the record date are
entitled  to notice of the Annual Meeting and to vote at the Annual Meeting.  On
the  record  date,  there  were  4,349,657  shares  of Common Stock outstanding.

WHAT  VOTE  IS  REQUIRED  TO  APPROVE  EACH  MATTER?

     Proposal  One  -  Election  of  Directors  - Directors will be elected by a
majority  of  the  votes  cast,  meaning  that  the number of votes cast "for" a
director  nominee  must  exceed the number of votes cast "against" that director
nominee.

     Proposal  Two  - Approval of the Amendment to our Amended and Restated 2004
Stock  Option  Plan - The affirmative vote of a majority of the shares of Common
Stock  present  or  represented by proxy at the meeting is needed to approve the
amendment  to  our  Amended  and  Restated  2004  Stock  Option  Plan.

     Proposal  Three - Approval of the Increase to the Authorized Common Stock -
The  affirmative  vote of the holders of a majority of the outstanding shares of
Common  Stock  entitled to vote at the meeting is needed to approve an amendment
to  our Second Amended and Restated Certificate of Incorporation to increase the
number  of  shares  of  authorized  Common  Stock.

     Proposal  Four - Ratification of the Selection of UHY LLP - The affirmative
vote of a majority of the shares of Common Stock present or represented by proxy
at  the  meeting is needed to ratify the selection of UHY LLP as our independent
registered  public accounting firm for the fiscal year ending December 31, 2009.

HOW  DO  I  VOTE?

     A  share  of  our Common Stock cannot be voted at the Annual Meeting unless
the  holder thereof is present or represented by proxy.  Whether or not you plan
to  attend  the  Annual  Meeting  in  person,  please  sign, date and return the
enclosed  proxy  card  as  promptly  as  possible  in  the postage paid envelope
provided  to ensure that there is a quorum and that your shares will be voted at
the Annual Meeting.  When proxies in the accompanying form are returned properly
executed  and  dated, the shares represented thereby will be voted at the Annual
Meeting.  If  a choice is specified in the proxy, the shares represented thereby
will  be  voted  in  accordance with such specification.  If no specification is
made,  the  proxy will be voted FOR approval of the all four proposals.  You may
also  vote  your  shares  via  the  telephone  by accessing the toll-free number
indicated  on  your  proxy  card  or via the internet by accessing the worldwide
website  indicated  on  your  proxy  card.

     If  you  hold  shares  through a bank, broker or other nominee, such entity
will  give  you  separate  instructions  on  voting  your  shares.

HOW  DO  I  REVOKE  MY  PROXY?

     Any  stockholder  giving a proxy has the right to revoke it any time before
it  is  voted  by filing with our Secretary a written revocation, or by filing a
duly executed proxy bearing a later date, or by attending the Annual Meeting and
voting  in person.  The revocation of a proxy will not be effective until notice
thereof  has  been  received  by our Secretary at the address of the company set
forth  above.

WHAT  CONSTITUTES  A  QUORUM?

     The  presence  at the Annual Meeting, in person or by proxy, of the holders
of  a  majority of the total number of shares of Common Stock outstanding on the
record  date  will  constitute  a quorum for the transaction of business by such
holders  at  the Annual Meeting.  Abstentions will be counted as shares that are
present  and  entitled  to  vote for purposes of determining whether a quorum is
present.  Shares held by nominees for beneficial owners also will be counted for
purposes  of  determining  whether  a  quorum  is present if the nominee has the
discretion  to  vote  on  at least one of the matters presented, even though the
nominee  may  not  exercise  discretionary  voting  power  with respect to other
matters  and  even  though  voting  instructions have not been received from the
beneficial  owner  (a  "broker  non-vote").

WHAT  ARE  MY  VOTING  RIGHTS?

     Holders of the Common Stock have one vote for each share on any matter that
may  be presented for consideration and action by the stockholders at the Annual
Meeting.  Stockholders  are not entitled to cumulative voting in the election of
directors.  All  of  the  proposals  will  require  the  affirmative vote of the
holders  of  a majority of the shares of the Common Stock present or represented
by  proxy  at  the  Annual  Meeting.

WHAT  EFFECT  WILL  ABSTENTIONS  AND  BROKER  NON-VOTES  HAVE  ON THE PROPOSALS?

     Shares  not  present  at  the  meeting  and shares voting "abstain" have no
effect  on  the  election  of  directors.  For  each  of  the  other  proposals,
abstentions  have  the  same effect as negative votes.  Broker non-votes (shares
held by brokers that do not have discretionary authority to vote on a matter and
have  not  received  voting instructions from their clients) would have the same
effect  as  negative  votes  on  Proposal Three (to amend the Second Amended and
Restated  Certificate  of  Incorporation)  but  will have no effect on the other
proposals.

COST  OF  SOLICITATION

     We  will  bear  the  cost  of  solicitation  of  proxies.  In  addition  to
solicitation  by  mail, directors and officers may solicit proxies by telephone,
facsimile  or  personal interview.  We will reimburse directors and officers for
their  reasonable  out-of-pocket  expenses in connection with such solicitation.
We  will  request brokers and nominees who hold shares in their names to furnish
these  proxy  materials  to  the  persons  for  whom  they  hold shares and will
reimburse  such brokers and nominees for their reasonable out-of-pocket expenses
in  connection  therewith.

EXECUTIVE  OFFICE

     Our  executive  office  is  located at 3450 West Central Avenue, Suite 328,
Toledo,  Ohio  43606.  Our  telephone  number  is  (419)  535-6374.

FORM  10-K  AVAILABLE

     A  COPY  OF  OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31,
2008,  INCLUDING  THE  FINANCIAL  STATEMENTS,  MAY BE OBTAINED WITHOUT CHARGE BY
WRITING  TO  JAMES  MCHUGH,  OUR CORPORATE SECRETARY, AT THE ABOVE ADDRESS.  The
Annual  Report is also available on our website at www.nviro.com under "Investor
                                                   -------------
Information".



                       PROPOSAL 1 - ELECTION OF DIRECTORS

     The  Board  of  Directors,  pursuant  to  our  Second  Amended and Restated
Certificate  of  Incorporation  and Second Amended and Restated By-Laws, has set
the number of directors to serve for the next year at seven, four of whom are to
be  elected  at  the  Annual Meeting to serve as Class I Directors.  Our By-Laws
provide  for  a  classified  Board  consisting  of  two  classes  of  equal  or
approximately  equal  number  based  on  the total number of directors fixed and
determined  by  a  vote of a majority of our entire Board serving at the time of
such  vote.  The  number  of directors is currently set at seven.  The directors
are  elected  for  a  two-year  term  or  until the election of their respective
successors  or  until  their  resignation,  removal  from  office  or  death.

     The Board is currently composed of six Directors - three Class I Directors:
Carl Richard, Joseph H. Scheib and Mark D. Hagans; and three Class II Directors:
James  H.  Hartung,  Timothy  R. Kasmoch and Thomas L. Kovacik (whose terms will
expire  upon  the election and qualification of directors at the annual meetings
of stockholders to be held in 2009 and 2010, respectively).  R. Francis DiPrete,
who  formerly served as a Class I Director, resigned from the Board effective on
May  18,  2009.

     Each  of our current Class I Directors - Carl Richard, Joseph H. Scheib and
Mark  D. Hagans - is presently standing for re-election to the Board.  The Board
has  nominated  Ms.  Joan  B.  Wills  for the director seat formerly held by Mr.
DiPrete.  If  elected,  the nominees each will serve for a term of two-years and
until  their  respective  successors  are  elected  or  until  their  earlier
resignation,  removal  from  office  or  death.

     Each  of  the nominees has consented to serve until his or her term expires
if elected at the Annual Meeting as a Class I Director.  If any nominee declines
or  is  unable  to accept such nomination to serve as a Class I Director, events
which  the  Board  does  not  now  expect,  the Board may designate a substitute
nominee,  in  which  event  the  proxies  reserve  the  right  to  vote for such
substitute  nominee.  The proxy solicited hereby will not be voted to elect more
than  four  Class  I  Directors.

     Under  our  By-Laws,  a  nominee  for Class I Director must be elected by a
majority  of  the  votes  cast,  meaning  that  the number of votes cast "for" a
director  nominee  must  exceed the number of votes cast "against" that director
nominee.  Under  Delaware  law,  if  an  incumbent  nominee  for  director in an
uncontested  election  does  not receive the requisite votes for reelection, the
director remains in office as a "holdover" director until a successor is elected
and  qualified.

     The Board adopted a policy under which the Board will nominate for election
or  re-election  as  a  Director  only  candidates who agree to tender, promptly
following their failure to receive the required vote for election or re-election
at  the  next  meeting  at  which  they  would  face election or re-election, an
irrevocable resignation that will be effective upon acceptance by the Board.  In
addition, the Board will fill Director vacancies and new directorships only with
candidates  who agree to tender the same form of resignation, promptly following
their  appointment to the Board.  Each of Messrs. Richard, Scheib and Hagans has
submitted  such  a  resignation  to  the  Board.

     THE  BOARD OF DIRECTORS RECOMMENDS THAT MESSRS. RICHARD, SCHEIB, HAGANS AND
MS.  WILLS  BE  ELECTED  AT  THE ANNUAL MEETING AS CLASS I DIRECTORS.  The Board
intends  to vote proxies received from stockholders for the election of the four
Class  I  Directors  named  above.

     Certain information about all of the directors and nominees for director is
furnished  below.

                            DIRECTORS OF THE COMPANY

     The  following table sets forth (i) the names and ages of our directors and
executive  officers  and the positions they hold, and (ii) the names and ages of
the  nominees  for  director  listed  herein.




Name                Age                           Position
------------------  ---  --------------------------------------------------------
                   
Mark D. Hagans      42   Class I Director *
James H. Hartung    66   Class II Director
Timothy R. Kasmoch  47   Class II Director, President and Chief Executive Officer
Thomas L. Kovacik   61   Class II Director
Carl Richard        82   Class I Director *
Joseph H. Scheib    52   Class I Director *
Joan B. Wills       56   Nominee for Class I Director



_____________
* Directors currently nominated for re-election.

MARK  D.  HAGANS is an attorney and partner with the law firm of Plassman, Rupp,
Short  &  Hagans,  of  Archbold,  Ohio, and his practice focuses on corporation,
taxation  and  banking  law.  Mr. Hagans serves on numerous Boards of directors,
including  the  Fulton  County Health Center, where he is presently chair of the
Finance  Committee.  Mr.  Hagans  earned  his  law degree from the University of
Toledo.  Mr.  Hagans  has  served  as  our Director since December 2006 and is a
member  of  the  Board's  Audit,  Finance  and  Technology  Committees.

JAMES  H.  HARTUNG  is  the  former President and Chief Executive Officer of the
Toledo-Lucas  County  (Ohio)  Port Authority, a position he held from 1994 until
2008.  Mr. Hartung has served as our Director since January 2006 and is a member
of  the  Board's  Compensation  and  Nominating  Committees.  Mr. Hartung's son,
Howard,  was  our Chief Operating Officer until his resignation in January 2008.

TIMOTHY  R.  KASMOCH  has  been  our President and Chief Executive Officer since
February  2006  and  a  Director  since  January 2006.  Until April 1, 2007, Mr.
Kasmoch  was  also  President  and  CEO  of  Tri-State  Garden  Supply,  d/b/a
Gardenscape,  a  bagger  and  distributor of lawn and garden products, which has
provided  trucking  services  to our Company.  Mr. Kasmoch is a graduate of Penn
State University.  Mr. Kasmoch is a member of the Board's Finance and Technology
Committees.

THOMAS  L.  KOVACIK  is  presently  employed  as  the  Executive  Director  of
Transportation  Advocacy Group of Northwest Ohio ("TAGNO"), a strategic planning
organization working with local and Ohio transportation and economic development
officials.  Mr.  Kovacik  was  previously  employed  by  us from 1992 to 1995 as
President  of Great Lakes N-Viro, at the time one of our divisions.  Mr. Kovacik
has  also  held  various  positions  with  local  government,  utilities  and
environmental  companies,  and  earned a masters degree from Bowling Green State
University  in  Geochemistry.  Mr.  Kovacik  has  served  as  our Director since
December  2006,  and  is  a  member  of  the Board's Compensation and Technology
Committees.

CARL  RICHARD  is  the former Executive Vice-President of P.R. Transportation, a
trucking  company  located  in  Toledo,  Ohio,  and  was a consultant to us from
January  2006  to  April  2007.  Mr.  Richard  served  as Vice-President of C.A.
Transportation  from  1988  through  2000  and  as  Vice-President  of  R.O.S.S.
Investments, a real estate holding company, from 1980 through 2000.  Mr. Richard
has  served  as  our Director since December 2004 and is a member of the Board's
Nominating  Committee.

JOSEPH  H. SCHEIB is the Chief Financial Officer of Broad Street Software Group,
a  comprehensive software technology company located in Edenton, North Carolina,
a  position he has held since June 2003.  From May 2000 until February 2003, Mr.
Scheib  was  the  Financial  Operation  Principal/Compliance Officer of Triangle
Securities,  LLC  of Raleigh, North Carolina, an asset management, brokerage and
investment  banking  firm.  Mr.  Scheib is a CPA and a graduate of East Carolina
University  with  a degree in accounting.  Mr. Scheib has served as our Director
since  December  2004,  and  is  a  member  of  the  Board's  Audit, Finance and
Nomination  Committees.

JOAN  B. WILLS is currently legal counsel for The Narragansett Bay Commission, a
regional sewer authority located in Providence, Rhode Island, a position she has
held  since  2008.  Also,  Ms.  Wills  is  currently Trustee of the Cooke Family
Trust,  an  owner  of  more  than  5% of N-Viro International Corporation common
stock.  From  2006  until  2008,  Ms.  Wills provided legal counsel to the Rhode
Island  Office  of  Legislative  Counsel,  an  agency  involved  in drafting new
legislation  and  amendments to the State of Rhode Island.  Ms. Wills has been a
practicing  attorney  at  various  points in her career, and holds a Bachelor of
Arts  degree  from  the  University  of  Rhode Island and a Juris Doctorate from
Suffolk  University  Law  School  in  Boston.

KEY  RELATIONSHIPS

Joan Wills is currently Trustee of the Cooke Family Trust, an owner of more than
5%  of  N-Viro  International  Corporation  common  stock.

                     CORPORATE GOVERNANCE AND BOARD MATTERS

MEETINGS  OF  THE  BOARD  OF  DIRECTORS

     Our  business,  property and affairs are managed under the direction of our
Board.  The  Board  presently  consists  of seven members.  Our Board held three
formal  meetings during 2008, consisting of two regular meetings and one special
meeting.  Each  director  attended 100% of the aggregate number of meetings held
by  the Board of Directors and the Committees of the Board of Directors on which
he served.  It is the policy of the Company that the members of the Board attend
our  annual stockholder meeting.  Failure to attend annual meetings without good
reason  is  a  factor  the  Nominating  Committee  and  Board  will  consider in
determining  whether to renominate a current Board member.  All seven members of
the  Board  attended  the  2008  Annual  Meeting.

SHAREHOLDER  COMMUNICATIONS  WITH  THE  BOARD

     We  encourage  stockholder communications with directors.  Stockholders may
communicate  with  a  particular  director, all directors or the Chairman of the
Board  by  mail or courier addressed to him or the entire Board in care of James
K.  McHugh,  Corporate  Secretary,  N-Viro  International Corporation, 3450 West
Central  Avenue, Suite #328, Toledo, OH  43606.  All correspondence should be in
a  sealed  envelope  marked "Confidential" and will be forwarded unopened to the
director  as  appropriate.

BOARD  INDEPENDENCE

     Although  we  are  not  subject  to  the  listing requirements of any stock
exchange, we are committed to a board in which a majority of our members consist
of  independent  directors,  as  defined  under the NASDAQ rules.  The Board has
reviewed  the  independence  of  its  members, applying the NASDAQ standards and
considering  other  commercial,  legal,  accounting  and  familial relationships
between  the  Directors  and  us.  The  Board  has  determined  that  all of the
Directors  and  director nominees are independent other than Mr. Kasmoch, who is
not  an  independent  Director  by  virtue  of his current position as our chief
executive  officer, and Mr. Hartung, who is deemed not to be independent because
his  son  was  employed  as  an executive officer of the Company within the past
three  years.

CODE  OF  ETHICS

     We  have  adopted a Code of Ethics which covers the Chief Executive Officer
and  Chief  Financial  Officer, which is administered and monitored by the Audit
Committee  of  the  Board.  A copy of the Code of Ethics was attached as Exhibit
14.1 to our Annual Report on Form 10-K for the year ended December 31, 2008, and
is  posted  on  our  web  site  at  www.nviro.com.
                                    -------------

COMMITTEES  OF  THE  BOARD  OF  DIRECTORS

     The  Board has the following standing committees:  the Audit Committee, the
Compensation  Committee, the Finance Committee, the Nominating Committee and the
Technology  Committee.  The  composition  and  function of each Committee is set
forth  below:





DIRECTOR            AUDIT  COMPENSATION  NOMINATING  FINANCE  TECHNOLOGY
                                               
Mark D. Hagans      X                                X*       X
James H. Hartung           X             X
Timothy R. Kasmoch                                   X        X*
Thomas L. Kovacik          X*                                 X
Carl Richard                             X
Joseph H. Scheib    X*                   X*          X


*  Committee Chair


AUDIT  COMMITTEE

     Our  Audit Committee consisted of Messrs. Scheib, Hagans and DiPrete, until
Mr.  DiPrete's  resignation  from the Board in May 2009.  In accordance with our
Audit  Committee  Charter,  each  of  the  Audit  Committee  members  must  be
"independent"  as  determined  under  the  NASDAQ  rules.   The  Audit Committee
currently  is not subject to, and does not follow, the independence criteria set
forth in Section 10A of the Securities Exchange Act 1934, as amended.  The Board
has  determined  that each of the directors who serve on the Audit Committee are
"independent"  under  the  NASDAQ  rules,  meaning  that  none  of  them  has  a
relationship  with us that may interfere with their independence from us and our
management.  Further,  the  Board  has determined that Mr. Scheib qualifies as a
"financial  expert"  as  defined  by the Securities and Exchange Commission (the
"SEC").

     The  Audit  Committee  recommends  the  appointment of the outside auditor,
oversees  our  accounting  and internal audit functions and reviews and approves
the  terms  of transactions between us and related party entities.  During 2008,
the  Audit  Committee met three times.  The Audit Committee has retained UHY LLP
to  conduct the audit for the year ended December 31, 2009.  The Audit committee
is  governed  by  a  written  charter, a copy of which was attached to the Proxy
Statement  for  our  annual  meeting  held  on  June  8,  2007.

COMPENSATION COMMITTEE

     The  Compensation  Committee  determines officers' salaries and bonuses and
administers  the grant of stock options pursuant to our stock option plans.  The
Compensation  Committee  does  not  have  a  written  charter.  The Compensation
Committee consisted of Messrs. Kovacik, Hartung and DiPrete, until Mr. DiPrete's
resignation  in May 2009.  The Compensation Committee met two times during 2008.

     The  Board  has  determined that a majority of the members of the committee
are  "independent" as determined under the NASDAQ standards.  Mr. Hartung is not
deemed to be "independent" due to his son, Howard Hartung, serving as one of our
executive  officers until January 2008.  Under the NASDAQ standards, Mr. Hartung
will  not  be  independent for at least three years after the resignation of his
son.  Despite  his  lack  of  "independence,"  the  Board  determined  that  Mr.
Hartung's exercise of independent judgment has not been and will not be affected
by  this  relationship.

FINANCE  COMMITTEE

     The  Finance  Committee,  consisting of Messrs. Hagans, Kasmoch and Scheib,
assists  in  monitoring  our cash flow requirements and approves any internal or
external financing or leasing arrangements.  The Finance Committee does not have
a  written  charter.  This  committee  met  once  during  2008.

NOMINATING  COMMITTEE

     The  Nominating  Committee,  consisting  of  Messrs.  Scheib,  Richard  and
Hartung, considers and recommends to the Board qualified candidates for election
as  Board  members,  and  establishes  and  periodically  reviews  criteria  for
selection  of  directors.  The  Nominating  Committee  does  not  have a written
charter.  The  committee  met  one  time  during  2008.

     The  Board  has  determined that a majority of the members of the committee
are "independent" as determined under the NASDAQ standards.   Mr. Hartung is not
deemed to be "independent" due to his son, Howard Hartung, serving as one of our
executive  officers until January 2008.  Under the NASDAQ standards, Mr. Hartung
will  not  be  independent for at least three years after the resignation of his
son.  Despite  his  lack  of  "independence,"  the  Board  determined  that  Mr.
Hartung's exercise of independent judgment has not been and will not be affected
by  this  relationship.

     The  Nominating  Committee  will  consider  candidates  recommended  by
stockholders,  directors,  officers,  third-party search firms and other sources
for  nomination  as  a director.  The Committee considers the needs of the Board
and  evaluates  each  director  candidate  in  light of, among other things, the
candidate's  qualifications.  Recommended  candidates  must  be  of  the highest
character  and  integrity,  free  of  any  conflicts of interest and possess the
ability  to  work  collaboratively  with  others, and have the time to devote to
Board  activities.  All  candidates  will  be  reviewed  in  the  same  manner,
regardless  of  the  source  of  the  recommendation.

     The  Nominating  Committee will consider all stockholder recommendations of
proposed  director  nominees,  if such recommendations are timely received under
applicable  SEC  regulations  and  include all of the information required to be
included  as  set  forth  in  the  By-Laws.  To be considered "timely received,"
recommendations  must be received in writing at our principal executive offices,
at  N-Viro International Corporation, 3450 W. Central Avenue, Suite 328, Toledo,
Ohio  43606,  Attention:  Chairman,  Nominating  Committee, c/o James K. McHugh,
Corporate  Secretary,  no  later  than  March  12,  2010.

     All  stockholder  recommended  candidates should be independent and possess
substantial  and  significant  experience  which  would be of value to us in the
performance  of the duties of a director.  In addition, any stockholder director
nominee  recommendation  must  include, at a minimum, the following information:
the  stockholder's  name;  address;  the  number  and class of shares owned; the
candidate's  biographical  information, including name, residential and business
address,  telephone  number, age, education, accomplishments, employment history
(including  positions  held  and  current  position),  and  current  and  former
directorships;  and  the  stockholder's  opinion  as  to whether the stockholder
recommended  candidate  meets  the definitions of "independent" under the NASDAQ
standards.  In  addition, the recommendation letter must provide the information
that  would  be  required  to  be  disclosed  in the solicitation of proxies for
election  of  directors  under  federal  securities  laws.  The stockholder must
include  the  candidate's  statement  that  he/she  meets these requirements; is
willing  to  promptly  complete  the  Questionnaire  required  of  all officers,
directors  and  candidates  for nomination to the Board; will provide such other
information  as  the  Committee may reasonably request; consents to serve on the
Board if elected; and a statement whether such candidate, if elected, intends to
tender, promptly following such person's election or re-election, an irrevocable
resignation  effective  upon  such person's failure to receive the required vote
for re-election at the next meeting at which such person would face re-election.

COMPENSATION OF DIRECTORS

     Our  Board  of  Directors  has approved the payment of cash compensation to
non-employee  directors  in exchange for their service on the Board.  The amount
of  cash compensation to be received by each non-employee director is $1,000 per
regular meeting attended during each calendar year, and $500 per special meeting
attended.  Our Board of Directors generally has four meetings per calendar year.
The  Directors  are  reimbursed for out-of-pocket expenses incurred in attending
meetings  of  the  Board  of  Directors  or  any  committees  thereof.

     Under  our  current  stock option plan, approved by the stockholders in May
2004  and  amended  by the stockholders in June 2008, each non-employee Director
automatically  receives  a  grant  of options to purchase 2,500 shares of Common
Stock  for each regular meeting attended, and an option to purchase 1,250 shares
of  Common  Stock  for  each  special  meeting attended, subject to a maximum of
options  to  purchase  15,000  in  any  year.

     Directors  who are our employees do not receive any additional compensation
for  serving as Directors.  Directors who are our consultants do not receive any
additional  cash  compensation  for  serving  as Directors, but do receive stock
options  per  the provisions of the N-Viro International Corporation Amended and
Restated  2004  Stock  Option  Plan.

     See  "Certain  Relationships  and  Related  Transactions"  for  additional
compensation  to  Directors.

                             DIRECTOR COMPENSATION




                       Fees                         Non-Equity    Non-Qualified   Non-Qualified
                    Earned or                        Incentive      Incentive        Deferred            All
                     Paid in     Stock    Option       Plan            Plan        Compensation         Other
Name                   Cash     Awards    Awards   Compensation    Compensation      Earnings     Compensation (1)    TOTAL
------------------  ----------  -------  --------  -------------  --------------  --------------  -----------------  --------
                                                                                             
R. Francis DiPrete  $    4,000        -  $ 13,525              -               -               -  $           2,500  $ 20,025
Joseph H. Scheib    $    4,000        -  $ 13,525              -               -               -                  -  $ 17,525
Carl Richard        $    4,000        -  $ 13,525              -               -               -                  -  $ 17,525
James H. Hartung    $    4,000        -  $ 13,525              -               -               -                  -  $ 17,525
Mark D. Hagans      $    4,000        -  $ 13,525              -               -               -                  -  $ 17,525
Thomas L. Kovacik   $    4,000        -  $ 13,525              -               -               -                  -  $ 17,525
Timothy R. Kasmoch           -        -         -              -               -               -                  -  $      0
                    ----------  -------  --------  -------------  --------------  --------------  -----------------  --------
                    $   24,000  $     0  $ 81,150  $           0  $            0  $            0  $           2,500  $107,650
                    ==========  =======  ========  =============  ==============  ==============  =================  ========



(1)  Represents  consulting fees paid to Mr. DiPrete as approved by the Board of
Directors.




              PROPOSAL 2 - ADOPTION OF AN AMENDMENT TO THE AMENDED
                      AND RESTATED 2004 STOCK OPTION PLAN

     In  April  2009,  our Board of Directors voted to adopt an amendment to the
Amended  and Restated 2004 Stock Option Plan to increase the number of shares of
Common  Stock  available  for  issuance  from 1,500,000 to 2,500,000, subject to
stockholder  approval  at  the  annual  meeting.  A  copy of the proposed Second
Amended  and Restated 2004 Stock Option Plan is attached to this proxy statement
as  Appendix  A.

     Our  stockholders originally approved the adoption of the 2004 Stock Option
Plan in June 2004, and approved the Amended and Restated 2004 Stock Option Plan,
increasing  the  number  of shares available under the plan by 500,000 shares to
1,500,000  shares,  in  June  2008.

     As of June 10, 2009, options to purchase 720,925 shares of our Common Stock
were  outstanding  under the plan, and options to purchase 167,000 shares of our
Common  Stock  under  the  plan  had  been  exercised. As a result, we only have
612,075  shares  available  for future grant under the Amended and Restated 2004
Stock  Option  Plan  as of June 10, 2009. We have no other stock incentive plans
under  which  we  may  grant  stock  options  or  other  stock-based  awards.

     Our  Board  of Directors believes that our future success depends, in large
part,  upon  the  ability  to  maintain  a  competitive  position in attracting,
retaining  and  motivating  qualified  officers,  other  key  employees  and
non-employee  Directors.  Accordingly,  our  Board  of  Directors  believes that
increasing  the  number of shares available for issuance pursuant to the Amended
and  Restated  2004  Stock  Option  Plan  is  in  our best interest and the best
interests  of  our  stockholders.  In  addition, increasing the number of shares
available  will  be consistent to maintain the percentage of shares in the Stock
Option  Plan  relative to the total number of shares authorized for the Company,
at 10%, assuming the approval of Proposal 3 to increase the number of authorized
shares  of  Common  Stock.

     The affirmative vote of a majority of the shares of Common Stock present or
represented  by  proxy  at the meeting is needed to approve the amendment to our
Amended  and  Restated  2004  Stock  Option  Plan.

     OUR  BOARD  OF  DIRECTORS RECOMMENDS A VOTE "FOR" THE AMENDMENT TO INCREASE
THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE PURSUANT TO THE AMENDED AND RESTATED
2004  STOCK  OPTION  PLAN  BY  AN  ADDITIONAL  1,000,000  SHARES.


DESCRIPTION  OF  THE  AMENDED  AND  RESTATED  2004  STOCK  OPTION  PLAN

     The  flowing  is  a  brief  summary  of the Amended and Restated 2004 Stock
Option  Plan.  References to our Board of Directors throughout this summary also
refer  to  any  committee  or officer which our Board of Directors has delegated
authority  with  respect  to  the  Amended  and  Restated 2004 Stock Option Plan

Purpose  of  the  Amended  and  Restated  2004  Stock  Option  Plan

     The  purpose  of  the  Amended  and  Restated  2004 Stock Option Plan is to
attract  and  retain  qualified  officers,  other key employees and non-employee
Directors,  and  to  provide  an  incentive for such officers, key employers and
Directors of the Company to expand and improve the profits and prosperity of the
Company.

Administration  and  Duration of the Amended and Restated 2004 Stock Option Plan

     The  Amended  and  Restated  2004  Stock Option Plan is administered by our
Board  of  Directors,  unless  the  Board delegates its authority to a committee
appointed  by  the  Board,  provided  that  all grants to persons who qualify as
"named  executive  officers" under Regulation S-K of the Securities and Exchange
Commission,  may  only  be  delegated  to  a committee that is comprised only of
directors  who  qualify  as  "non-employee directors" within the meaning of Rule
16b-3  under  the  Securities  Exchange  Act of 1934, and as "outside directors"
within  the meaning of the Internal Revenue Code (the "Code") Section 162(m) and
the regulations promulgated under such section. The administrator of the Amended
and  Restated 2004 Stock Option Plan is authorized, subject to the provisions of
the  Amended  and  Restated  2004 Stock Option Plan, to establish such rules and
regulations  as  it  may  deem  appropriate for the proper administration of the
Amended  and  Restated  2004  Stock Option Plan, and to make such determinations
under,  and  such interpretations of, and to take such steps in connection with,
the  Amended  and Restated 2004 Stock Option Plan and plan awards as it may deem
necessary  or  advisable.

The Amended and Restated 2004 Stock Option Plan will have a duration of 10 years
from  the  date  the  2004 Stock Option Plan became effective.  Accordingly, the
Amended  and  Restated  2004  Stock Option Plan will terminate on June 30, 2014,
unless  sooner  terminated by the Board.  Upon such termination, the outstanding
awards granted under the Amended and Restated 2004 Stock Option Plan will remain
in  effect  until  their exercise, expiration, or termination.  The Board may at
any time terminate the Amended and Restated 2004 Stock Option Plan, or amend the
Amended  and  Restated  2004  Stock  Option Plan as it deems advisable; provided
that, to the extent determined by our Board of Directors, no amendment requiring
stockholder  approval  under  any  applicable  legal,  regulatory  or  listing
requirement  will  become effective until such stockholder approval is obtained.
Stockholder  approval  will  be required for any amendment for which stockholder
approval  is  required  under  Section  422 of the Code or the rules of an stock
exchange  on  which  our  Common  Stock  is  listed.

Types  of  Awards

     The  Amended  and  Restated  2004  Stock  Option  Plan provides for certain
automatic  grants to non-employee Directors of options to purchase shares of our
Common  Stock, and authorizes the administrator to grant awards of stock options
to  other  eligible  participants.  The  participants  to whom option awards are
granted  by the administrator and the terms of the awards granted, including the
number  of  shares of Common Stock subject to such option awards, are within the
discretion  of  the administrator, subject to the terms and conditions set forth
in  the  Amended  and  Restated  2004  Stock  Option  Plan.

     Discretionary Awards; Option Price and Term.  Stock option awards under the
Amended  and  Restated  2004  Stock Option Plan may be in the form of "incentive
stock  options,"  which are options that meet the requirements of Section 422 of
the  Internal  Revenue  Code, or "nonqualified stock options," which are options
that  do  not meet such requirements. Except for incentive stock options granted
to  stockholders  owning more than 10% of the voting power of all classes of our
capital stock, the per share exercise price of an incentive stock option granted
or to be granted pursuant to the Amended and Restated 2004 Stock Option Plan, as
determined  by  the  administrator,  will be an amount not less than 100% of the
fair  market  value  of  a  share of Common Stock on the date that the option is
granted.

For  purposes  of the Amended and Restated 2004 Stock Option Plan, if the Common
Stock  is publicly traded, the "fair market value" of a share of Common Stock is
determined  by reference to the average closing price or to the mean between the
closing  dealer  bid  and  asked prices for the Common Stock, as reported on any
stock  exchange  on  which  the Common Stock is then traded, for the ten trading
days  immediately  preceding the day on which the grant is made.  For periods in
which  no trades or quotations have been reported for at least ten business days
in  the thirty calendar days before the date of grant, the fair market value may
be  determined  by  reference  to  an  average  of the closing or trading prices
reported  during  the  prior  month  or  in  such  other  manner as the Board or
committee  may deem to be an appropriate method of estimating the current market
value.

As  to  nonqualified  stock  options granted under the Amended and Restated 2004
Stock  Option Plan, the per share exercise price of such options will also be at
least  100%  of  the fair market value of a share of Common Stock on the date of
grant.

     The  term of each option awarded by the administrator will be determined by
the  administrator,  but  in no event in excess of 10 years from the date of its
grant.  Payment  of  the  exercise price may be made in cash or by check, or, if
approved  by  the  administrator, by delivery of shares of Common Stock owned by
the  participant  for  at  least  six months which are equivalent in fair market
value  to  the  exercise price, or by a combination of cash and shares of Common
Stock,  at  the  election  of  the  optionee  and  subject  to  the terms of the
applicable  stock  option  agreement.  Subject to the terms of each stock option
agreement, options granted under the Amended and Restated 2004 Stock Option Plan
may  be  exercised  in  whole  or  in  part.  Upon  exercise  of  an option, the
participant  must  pay in full the exercise price for the shares of Common Stock
being  purchased.

Automatic  Option  Awards  for Non-Employee Directors. After the Annual Meeting,
each  non-employee  Director  who  attends  a  regular meeting of the Board will
automatically be granted a nonqualified stock option to purchase 2,500 shares of
our  Common  Stock,  effective  as of the date of the Board meeting.  Also, each
non-employee  Director  who  attends  a  special  meeting  of  the  Board  will
automatically  be  granted a non-qualified stock option to purchase 1,250 shares
of our Common Stock effective as of the date of the Board meeting, provided that
the  options  granted to a non-employee Director during a single calendar are to
be limited to options to purchase a maximum of 15,000 shares. The exercise price
for  each  option  will be equal to the fair market value of the Common Stock on
the meeting date, or if the meeting is not held on a business day, the preceding
business day.  Each option will become exercisable six (6) months after the date
of  grant,  and  will  have  a  10-year  term.

Shares  Subject  to  Awards

     Subject  to  approval  of  the  proposed amendment, the number of shares of
Common  Stock that may be issued by outstanding awards granted under the Amended
and  Restated 2004 Stock Option Plan will not in the aggregate exceed 2,500,000,
which  may  be original issue shares, treasury shares, or a combination thereof.
If  the proposed amendment is not approved, the number of shares of Common Stock
that  may  be  issued under the Amended and Restated 2004 Stock Option Plan will
not  in  the  aggregate  exceed  1,500,000.

     To the extent that awards granted under the Amended and Restated 2004 Stock
Option  Plan  expire  or  terminate  without  having been exercised in full, the
Common Stock subject to those expired or terminated awards will become available
for  further award grants under the Amended and Restated 2004 Stock Option Plan.
Provision  is  made  under  the  Amended and Restated 2004 Stock Option Plan for
appropriate  adjustment  in  the number of shares of Common Stock covered by the
Amended  and  Restated 2004 Stock Option Plan, and covered by each award granted
thereunder  and  any  related  exercise  or  purchase price, in the event of any
change  in  the  Common  Stock  by  reason  of  a  stock  dividend,  merger,
reorganization,  stock  split, recapitalization, combination, exchange of shares
or  otherwise.

Eligibility  and  Extent  of  Participation

     In  addition  to  our  non-employee Directors, all of our employees who are
designated  by  the  administrator for participation in the Amended and Restated
2004  Stock  Option  Plan  are  eligible to receive awards under the Amended and
Restated  2004  Stock  Option  Plan.  As  of  the  date  hereof,  there  were
approximately  28 individuals employed by us who were eligible to participate in
the Amended and Restated 2004 Stock Option Plan.  No incentive stock option will
be  granted  to any employee who, immediately after such option is granted, owns
our capital stock possessing more than 10% of the total combined voting power or
value  of  all classes of our capital unless the exercise price at the time such
incentive  stock  option is granted is at least 110% of the fair market value of
the shares subject to the incentive stock option and such incentive stock option
is not exercisable by its terms after the expiration of five years from the date
of  its  grant.

     The administrator may also, in the exercise of its discretion, grant awards
under the Amended and Restated 2004 Stock Option Plan to consultants who are not
our  employees,  except  that incentive stock options may not be granted to such
non-employees.  An  incentive stock option will be granted under the Amended and
Restated 2004 Stock Option Plan to an employee only if the aggregate fair market
value  (determined as of the date the option is granted) of the Common Stock for
which  options  are  exercisable  for the first time by such employee during any
calendar  year  does  not  exceed  $100,000. Options granted to all participants
during  a  single  calendar year shall be limited under the Amended and Restated
2004  Stock Option Plan so that such options shall in no event cover more than a
maximum  of 200,000 shares of Common Stock, unless the Board of Directors amends
the  plan  to  increase  such  maximum.

Limitations  on Transferability and Effect of Death or Termination of Employment

     Except as otherwise provided by the administrator, awards granted under the
Amended and Restated 2004 Stock Option Plan are generally not transferable other
than  by  will  or  by  the laws of descent and distribution. If a participant's
employment  (or  other relationship, in the case of a consultant or director) is
involuntarily  terminated,  or  is  terminated  by  the  participant without our
express  consent, for any reason other than retirement, disability or death, his
or  her  unvested  options  will  terminate  upon the date of the termination of
employment,  unless  the administrator decides, in its sole discretion, to waive
this termination and causes the participant's option agreement to provide for an
extended  exercise  period  after  such  termination.  The  administrator  will
determine, either in an award agreement or otherwise, the extent to which vested
options  may  be  exercised  subsequent  to  the  death  of  the employee or the
termination  of the employee's employment.  However, any incentive stock options
granted under the Amended and Restated 2004 Stock Option Plan must terminate not
later than ninety days after the participant's termination of employment for any
reason  other  than  disability  or  death, and it must terminate not later than
twelve  months  after the participant's termination of employment as a result of
death  or  disability.

Plan  Benefits

     As  of  June  10,  2009,  approximately 33 persons were eligible to receive
awards  under  the  Amended  and  Restated 2004 Stock Option Plan, including our
employees,  executive  officers  and  Directors.  Other than automatic grants of
options  to  Directors  pursuant  to  the Amended and Restated 2004 Stock Option
Plan,  the  granting  of awards under the Amended and Restated 2004 Stock Option
Plan  is  discretionary  and  we  cannot  now  determine  the  number  of shares
underlying  the  options to be granted in the future to any particular person or
group.

     The  table  below  sets forth information regarding options we have granted
under the Amended and Restated 2004 Stock Option Plan since its adoption through
June  10,  2009.




                                                                   NUMBER OF SECURITIES   WEIGHTED AVERAGE
                                                                    UNDERLYING OPTIONS   PER SHARE EXERCISE
NAME AND POSITION                                                        GRANTED                PRICE
                                                                                   
Timothy R. Kasmoch, President and Chief Executive Officer                       252,500  $              2.00
Robert W. Bohmer, V.P. Business Development and General Counsel                 100,000  $              2.80
James K. McHugh, Chief Financial Officer, Secretary and Treasurer                62,000  $              2.02
All current executive officers as a group                                       414,500  $              2.19
All current Directors who are not executive officers as a group                 199,100  $              2.34
All employees who are not executive officers as a group                             -0-




Federal Income Tax Consequences

     The  following  is  a  summary  of  the  United  States  federal income tax
consequences  that generally will arise with respect to awards granted under the
Amended  and  Restated  2004  Stock  Option  Plan.  This summary is based on the
federal  tax laws in effect as of the date of this proxy statement. In addition,
this  summary assumes that all awards are exempt from, or comply with, the rules
under  Section  409A  of  the Code regarding nonqualified deferred compensation.
The  plan  provides that no award will provide for deferral of compensation that
does  not comply with Section 409A of the Code, unless the Board, at the time of
grant,  specifically  provides  that  the  award  is not intended to comply with
Section  409A.  Changes to these laws could alter the tax consequences described
below.

     Incentive Stock Options.  A participant will not have income upon the grant
of  an  incentive  stock option.  Also, except as described below, a participant
will  not  have  income  upon  exercise  of  an  incentive  stock  option if the
participant  has  been our employee at all times beginning with the option grant
date  and  ending  three  months  before  the date the participant exercises the
option.  If  the participant has not been so employed during that time, then the
participant  will  be  taxed  as  described  below  under  "Non-statutory  Stock
Options."  The exercise of an incentive stock option may subject the participant
to  the  alternative  minimum  tax.

     A participant will have income upon the sale of the stock acquired under an
incentive  stock  option  at  a  profit (if sales proceeds exceed the sum of the
exercise  price).  The  type of income will depend on when the participant sells
the  stock.  If  a  participant  sells  the  stock more than two years after the
option  was  granted and more than one year after the option was exercised, then
all  of  the  profit will be long-term capital gain.  If a participant sells the
stock  prior to satisfying these waiting periods, then the participant will have
engaged  in  a  disqualifying  disposition  and  a portion of the profit will be
ordinary  income  and  a portion may be capital gain.  This capital gain will be
long-term  if  the  participant  has  held  the stock for more than one year and
otherwise will be short-term.  If a participant sells the stock at a loss (sales
proceeds  are  less  than  the  exercise price), then the loss will be a capital
loss.  This capital loss will be long-term if the participant held the stock for
more  than  one  year  and  otherwise  will  be  short-term.

     Non-statutory  Stock  Options.  A participant will not have income upon the
grant  of  a  non-statutory  stock option.  A participant will have compensation
income  upon  the exercise of a non-statutory stock option equal to the value of
the  stock  on  the  day  the participant exercised the option less the exercise
price.  Upon  sale  of the stock, the participant will have capital gain or loss
equal to the difference between the sales proceeds and the value of the stock on
the  day  the option was exercised.  This capital gain or loss will be long-term
if  the participant has held the stock for more than one year and otherwise will
be  short-term.

     Tax  Consequences  to  Us.  There will be no tax consequences for us except
that  we  will  be  entitled  to a deduction when a participant has compensation
income.  Any such deduction will be subject to the limitations of Section 162(m)
of  the  Code.


     PROPOSAL 3 - ADOPTION OF AMENDMENT TO THE SECOND AMENDED AND RESTATED
                        CERTIFICATE OF INCORPORATION TO
            INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK

     In April 2009, our Board approved, subject to adoption by our stockholders,
an  amendment  to  the  Second Amended and Restated Certificate of Incorporation
(the  "Certificate").  The  proposed  amendment is set forth in the Amendment to
Second  Amended and Restated Certificate of Incorporation attached to this proxy
statement  as  Appendix  B.

     The  proposed  amendment  to Article Four of the Certificate would increase
the  number  of authorized shares of Common Stock from 15,000,000 to 25,000,000.
As  a  result of the proposed increase, the total number of authorized shares of
capital  stock  of  the Company would be increased to 27,000,000. The additional
shares  of  Common  Stock  proposed to be authorized under the Certificate would
have  rights  identical  to  currently  outstanding  Common  Stock.

     As  of  June  10,  2009, there were 4,349,657 shares of Common Stock and no
shares  of  Preferred  Stock issued and outstanding. In addition, as of the same
date,  the  Board  of  Directors had reserved an aggregate of 751,325 shares for
issuance upon exercise of outstanding options and stock awards granted under the
1998  Amended  and  Restated Stock Option Plan and the Amended and Restated 2004
Stock Option Plan, and an aggregate of 726,472 shares for issuance upon exercise
of  outstanding  warrants to purchase shares of Common Stock. Accordingly, as of
June  10,  2009,  9,172,546  shares  of  Common  Stock  and  2,000,000 shares of
Preferred  Stock  remained  unreserved  and  available  for  future  issuance.

     Our  Board  of  Directors believes that the authorization of the additional
shares  of Common Stock is necessary to provide us with the flexibility to issue
shares  of  Common  Stock  in  connection with possible future financings, joint
ventures,  acquisitions,  stock  incentive  plans  and  other  general corporate
purposes,  without the expense and delay of further stockholder approval.  These
purposes  may include raising funds to meet our working capital needs, providing
equity  incentives  to  employees, officers or Directors, establishing strategic
relationships  with other companies, expanding our business through acquisitions
and  other  investment  opportunities  and  other  purposes.

     On  May  18,  2009,  our  Board  of Directors approved an offering of up to
$1,000,000  of  Convertible  Debentures (the "Debentures"), convertible into our
common  stock  at  $2.00  per share. Between May 26, 2009 and June 9, 2009, as a
part  of  our  continuing  offering  of  the  Debentures,  we issued $160,000 of
Debentures  to  five  (5)  accredited  investors.

     The  Company  may  pursue  other  capital raising activities in the future,
including  the issuance of Common Stock or securities converting or exchangeable
into  shares  of  Common  Stock.  In  addition,  in this proxy statement, we are
seeking  stockholder  approval for an amendment to our Amended and Restated 2004
Stock  Option  Plan  to increase the number of shares of Common Stock authorized
for  issuance  under  that  plan.

     If  this  Proposal 3 is adopted by the stockholders, our Board of Directors
will have authority to issue these additional shares of Common Stock without the
necessity  of  further  stockholder  action. Holders of the Common Stock have no
preemptive  rights  with respect to any shares that may be issued in the future.

     Although  the  Board  of  Directors  does  not consider Proposal 3 to be an
anti-takeover measure, the increase in the number of authorized shares of Common
Stock  and  the issuance of a substantial amount of such shares, or an option to
acquire  a  substantial amount of such shares, could have the effect of delaying
or  preventing  a change-of-control of the Company without further action by the
stockholders.  For example, the issuance of additional shares could decrease the
share ownership percentage of a person seeking to obtain control of the Company.

     The  holders  of all classes of stock are not entitled to preemptive rights
with respect to the issuance of additional stock or securities convertible into,
or  exercisable  for,  stock.  Approval  of  the  amendment  and issuance of the
additional  stock  would  not  affect the rights of the holders of our currently
outstanding  stock,  except  for  effects incidental to increasing the number of
shares  of our stock outstanding, such as dilution of the earnings per share and
voting  rights  of  current  holders  of  stock.

     Adoption  of  Proposal  3 requires the affirmative vote of the holders of a
majority  of  our  outstanding  shares  of  Common Stock entitled to vote at the
meeting. Under Delaware law, stockholders are not entitled to dissenter's rights
with  respect  to the proposed amendment to our Amended and Restated Certificate
of  Incorporation.

     If  Proposal  3  is  adopted  by  the  stockholders,  we intend to file the
amendment to the Second Amended and Restated Certificate of Incorporation in the
form  attached  to  this  proxy  statement as Appendix B, promptly following the
annual  meeting.

OUR  BOARD  OF  DIRECTORS  RECOMMENDS  THAT  YOU  VOTE "FOR" THE ADOPTION OF THE
AMENDMENT  TO  THE  CERTIFICATE  TO  INCREASE THE NUMBER OF AUTHORIZED SHARES OF
COMMON  STOCK.


      PROPOSAL 4 - RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITORS

     The  firm  of  UHY  LLP  served  as independent auditors for the year ended
December  31,  2008  and  has  been  selected  by us to serve as our independent
auditors for the year ending December 31, 2009.  Although the submission of this
matter  for  approval  by  the  stockholders  is not legally required, the Board
believes that such submission follows sound business practice and is in the best
interests  of  the  stockholders.  If  the  appointment  is  not ratified by the
holders  of a majority of the shares present in person or by proxy at the Annual
Meeting,  the  Directors will consider the selection of another accounting firm.
If such a selection were made, it may not become effective until 2010 because of
the  difficulty  and expense of making such a substitution.  A representative of
UHY  is expected to attend the Annual Meeting and therefore will be available to
respond  to  appropriate  questions  at  the  Annual  Meeting.

     The  audit  reports of UHY on our consolidated financial statements for the
fiscal  years  ended  December  31,  2008  and  2007 did not contain any adverse
opinion  or  disclaimer  of  opinion,  nor were they qualified or modified as to
audit  scope  or  accounting  principles.

     OUR  BOARD  OF  DIRECTORS  UNANIMOUSLY  RECOMMENDS  THAT YOU VOTE "FOR" THE
RATIFICATION  OF THE APPOINTMENT OF UHY LLP TO SERVE AS OUR INDEPENDENT AUDITORS
FOR  THE  YEAR  ENDING  DECEMBER  31,  2009.


                                 OTHER MATTERS

     We  are  not  aware of any matters to be presented for action at the Annual
Meeting  other  than  the  matters  set  forth  above.  If  any other matters do
properly come before the meeting or any adjournment thereof, it is intended that
the  persons  named  in the proxy will vote in accordance with their judgment on
such  matters.


         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     We  had  outstanding  4,349,657  shares of Common Stock, $.01 par value per
share,  or  the Common Stock, on June 10, 2009, which constitutes the only class
of  our  outstanding  voting  securities.

FIVE PERCENT STOCKHOLDERS

     At  June  10,  2009, the following were the only persons known to us to own
beneficially  more  than  5%  of  the  outstanding  shares  of  Common  Stock:




                                      Name                                Amount and          Percentage of
Title of                         and Address of                           Nature of        Outstanding Shares
Class                           Beneficial Owner                     Beneficial Ownership    of Common Stock
                                                                                  
------------  -----------------------------------------------------  --------------------  -------------------
              Cooke Family Trust (1)
              90 Grande Brook Circle, #1526
Common Stock  Wakefield, Rhode Island 02879                                       753,887                17.2%
------------  -----------------------------------------------------  --------------------  -------------------



1.     The  shares  attributed  to  the  Cooke  Family  Trust  include  708,887  shares  owned
beneficially  and  45,000  in Common Stock warrants exercisable to purchase an equal number of
shares  of Common Stock.  This information was derived from the Schedule 13D Amendment #4 filed
on  June 13, 2008.





SECURITY  OWNERSHIP  OF  MANAGEMENT
     The  following  table  sets  forth,  as  of June 10, 2009, unless otherwise
specified,  certain  information with respect to the beneficial ownership of our
shares  of  Common  Stock  by each person who is our director, a nominee for the
Board,  each of the Named Executive Officers, and by our directors and executive
officers  as  a  group.  Unless  otherwise  noted,  each  person  has voting and
investment  power, with respect to all such shares, based on 4,349,657 shares of
Common  Stock outstanding on the record date.  Pursuant to the rules of the SEC,
shares of Common Stock which a person has the right to acquire within 60 days of
the  date  hereof  pursuant  to  the  exercise of stock options are deemed to be
outstanding for the purpose of computing the percentage ownership of such person
but  are  not  deemed  outstanding  for  the purpose of computing the percentage
ownership  of  any  other  person.




                                                       Amount and Nature of
Title of Class        Name of Beneficial Owner         Beneficial Ownership  1     Percent of Class
--------------  -------------------------------------  --------------------       -----------------
                                                                      
Common Stock    R. Francis DiPrete                                  145,940  2                3.26%
Common Stock    Mark D. Hagans                                       15,400  3                0.35%
Common Stock    James H. Hartung                                     33,500  4                0.76%
Common Stock    Timothy R. Kasmoch                                  410,500  5                8.82%
Common Stock    Thomas L. Kovacik                                    13,750  6                0.32%
Common Stock    Carl Richard                                        140,269  7                3.16%
Common Stock    Joseph H. Scheib                                    196,138  8                4.42%
Common Stock    Joan B. Wills                                       753,887  9               17.33%
Common Stock    Robert W. Bohmer                                    102,600  10               2.31%
Common Stock    James K. McHugh                                      91,920  11               2.07%
                All directors and executive officers
Common Stock                as a group (10 persons)               1,903,904  12              36.60%



1.     Except  as otherwise indicated, all shares are directly owned with voting
and  investment  power  held  by  the  person  named.

2.     Represents  14,390  shares  of  Common Stock owned by Mr. DiPrete, 67,850
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $0.70  to  $3.90 per share and 63,700 unregistered shares
issuable  upon exercise of warrants which are currently exercisable at $2.00 per
share.

3.     Represents  2,900  shares  of Common Stock owned by Mr. Hagans and 12,500
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $1.82  to  $3.90  per  share.

4.     Represents  2,500  shares  of  Common  Stock owned by Mr. Hartung, 20,000
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $1.42  to  $3.90 per share and 11,000 unregistered shares
issuable  upon exercise of warrants which are currently exercisable at $2.00 per
share.

5.     Represents  100,000  unregistered  shares  and 8,000 registered shares of
Common  Stock  owned  by  Mr.  Kasmoch, 50,000 unregistered shares issuable upon
exercise  of  warrants  which  are  currently exercisable at $1.85 per share and
252,500 shares issuable upon exercise of options which are currently exercisable
at  prices  ranging  from  $1.70  to  $2.00  per  share.

6.     Represents  1,000  shares of Common Stock owned by Mr. Kovacik and 12,750
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $1.82  to  $3.90  per  share.

7.     Represents  51,000  shares  of  Common Stock owned by Mr. Richard, 31,250
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $0.70  to  $3.90 per share and 58,019 unregistered shares
issuable  upon  exercise  of  warrants which are currently exercisable at prices
ranging  from  $1.85  to  $2.00  per  share.

8.     Represents  106,238  shares  of  Common Stock owned by Mr. Scheib, 35,000
shares  issuable  upon  exercise  of  options which are currently exercisable at
prices  ranging  from  $0.70  to  $3.90  per share, 600 shares owned by a family
member  over  which  Mr. Scheib acts as custodian and 54,300 unregistered shares
issuable  upon  exercise  of  warrants which are currently exercisable at prices
ranging  from  $1.85  to  $2.00  per  share.

9.     Represents  753,887  shares  of  Common  Stock  owned by the Cooke Family
Trust,  a  more  than  5%  stockholder  of  which Ms. Wills is the trustee.  See
further  information  in  the  section  "Five  Percent  Stockholders".

10.     Represents  2,600 shares of Common Stock owned by Mr. Bohmer and 100,000
shares  issuable  upon  exercise  of  options which are currently exercisable at
$2.80  per  share.

11.     Represents  8,920 shares of Common Stock owned by Mr. McHugh and a total
of  83,000  shares  issuable  upon  exercise  of  options  which  are  currently
exercisable  at  prices  ranging  from  $1.50  to  $5.00  per  share.

12.     Represents  297,548  shares  of  Common Stock owned by the Directors and
Officers, 754,487 shares owned indirectly, 614,850 shares issuable upon exercise
of options which are currently exercisable at prices ranging from $0.70 to $5.00
per  share  and a total of 237,019 unregistered shares issuable upon exercise of
warrants  which  are currently exercisable at prices ranging from $1.85 to $2.00
per  share.





                       EXECUTIVE OFFICERS OF THE COMPANY

     Executive  officers  of the Company are appointed by the Board of Directors
and  hold  office at the pleasure of the Board.  Set forth below is biographical
and  other  information  on  the current executive officers of the Company.  Mr.
Kasmoch also serves as a member of the Board and his biographical information is
set  forth  above  under  the  caption  "Directors  of  the  Company."




Name                Age                      Position
------------------  ---  ------------------------------------------------
                   

Timothy R. Kasmoch   47  President and Chief Executive Officer
Robert W. Bohmer     40  V.P. Business Development and General Counsel
James K. McHugh      50  Chief Financial Officer, Secretary and Treasurer




ROBERT  W.  BOHMER  has  been  our  Vice-President  for Business Development and
General  Counsel  since July 2007.  Since 1996, Mr. Bohmer has been with the law
firm of Watkins, Bates and Carey, LLP, Toledo, Ohio.  Since 2005, Mr. Bohmer has
served  as  general  outside  counsel  to  the  Company.

JAMES  K.  MCHUGH  has  served  as  our  Chief  Financial Officer, Secretary and
Treasurer since January 1997.  Prior to that date, Mr. McHugh served the Company
and  our  predecessor  company  in various financial positions since April 1992.

                             EXECUTIVE COMPENSATION

COMPENSATION  OF  EXECUTIVE  OFFICERS

     The  following  table  presents  the  total  compensation paid to our Chief
Executive  Officer, V.P. Business Development and Chief Financial Officer during
2008.  There  were  no  other  executive officers who were serving at the end of
2008  and  whose  total  compensation  exceeded  $100,000.

                           SUMMARY COMPENSATION TABLE




                                                                      Non-Equity   Nonqualified
                                                                      Incentive      Deferred
Name and Principal                                 Stock    Option       Plan      Compensation    All Other
Position                   Year   Salary   Bonus  Awards    Awards   Compensation    Earnings    Compensation    Total
-------------------------  ----  --------  -----  -------  --------  ------------  ------------  -------------  --------
                                                                                     
Timothy R. Kasmoch         2008  $150,000      -        -  $      0             -             -  $           0  $150,000
President and Chief        2007  $139,788      -  $ 7,875  $      0             -             -  $           0  $147,663
  Executive Officer (1)

Robert W. Bohmer           2008  $150,000      -        -  $ 93,333             -             -  $           0  $243,333
V.P. Business Develop. +   2007  $ 75,000      -        -  $ 70,000             -             -  $           0  $145,000
  General Counsel (2)

James K. McHugh            2008  $100,044      -        -         -             -             -  $         552  $100,596
Chief Financial Officer,   2007  $ 93,945      -        -         -             -             -  $         360  $ 94,305
  Secretary + Treasurer (3)




(1)     Mr.  Kasmoch  was appointed CEO on February 14, 2006, effective with his
employment  date.  Mr.  Kasmoch  received  $7,875  for the value of unregistered
shares  of  Common  Stock  in  2007,  pursuant  to  the  terms of his Employment
Agreement  signed  February  14,  2006.

(2)     Mr.  Bohmer  was appointed V.P. Business Development and General Counsel
and  started  his  employment  on  July  1,  2007.  He was granted 100,000 stock
options  pursuant  to  our  Amended  and  Restated  2004  Stock  Option Plan, in
accordance with his Employment Agreement dated June 12, 2007.  In June 2008, his
employment  agreement  was extended for two (2) additional years.  These options
were  valued at $70,000 for 2007, revalued at $93,333 for 2008 and $280,000 over
the  four-year  life  of  his  employment  agreement.

(3)     Mr.  McHugh  is  taxed on the imputed benefit of a life insurance policy
that  benefits  his  personal beneficiary for one-half the face value and N-Viro
International  Corporation  for  one-half  the  face  value  of  the  policy.





                  OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END



                                            OPTION AWARDS                                         STOCK AWARDS
                    ---------------------------------------------------------------------  --------------------------
                                                       Equity
                                                      Incentive
                                                        Plan                                                Market
                         # of            # of          Awards:                                 # of        Value of
                      Securities      Securities    # Securities                             Shares or     Shares or
                      Underlying      Underlying     Underlying                              Units of      Units of
                     Unexercised     Unexercised     Unexercised     Option      Option     Stock That    Stock That
                     Options (#)     Options (#)      Unearned      Exercise   Expiration    Have Not      Have Not
Name                 Exercisable    Unexercisable    Options (#)   Price (#)      Date      Vested (#)    Vested ($)
------------------  --------------  --------------  -------------  ----------  ----------  -------------  -----------
                                                                                     
Timothy R. Kasmoch           2,500               -              -  $     1.70     2/15/16              -            -
Timothy R. Kasmoch         250,000               -              -  $     2.00    12/31/09              -            -

Robert W. Bohmer           100,000               -              -  $     2.80     6/13/17              -            -

James K. McHugh              6,000               -              -  $     5.00     5/12/10              -            -
James K. McHugh              5,000               -              -  $     1.50    12/15/10              -            -
James K. McHugh             10,000               -              -  $     1.50     12/7/11              -            -
James K. McHugh             12,000               -              -  $     2.10    11/11/14              -            -
James K. McHugh             50,000               -              -  $     2.00    12/31/16              -            -


                                STOCK AWARDS
                    -------------------------------
                       Equity           Equity
                      Incentive       Incentive
                    Plan Awards:     Plan Awards:
                     # Unearned       Market or
                       Shares,       Payout Value
                      Units or       of Unearned
                    Other Rights    Shares, Units
                      That Have    or Other Rights
                         Not          That Have
Name                 Vested (#)     Not Vested (#)
------------------  -------------  ----------------
                             
Timothy R. Kasmoch              -                 -
Timothy R. Kasmoch              -                 -

Robert W. Bohmer                -                 -

James K. McHugh                 -                 -
James K. McHugh                 -                 -
James K. McHugh                 -                 -
James K. McHugh                 -                 -
James K. McHugh                 -                 -





     All  options  awards  were  made  granted under the Company's current stock
option  plan described under the caption "Equity Compensation Plan Information."

EMPLOYMENT  AGREEMENTS

     On  February  13,  2007,  we  entered into an employment agreement with Mr.
Timothy  R. Kasmoch as our President and Chief Executive Officer.  Mr. Kasmoch's
employment  agreement is for a two-year term commencing on February 13, 2007 and
provides  for  automatic  renewal  of successive one-year terms unless notice is
provided ninety (90) days prior to the expiration of the then current term.  The
agreement  provides  that  Mr.  Kasmoch  is  to receive an annual base salary of
$150,000,  subject  to  an  annual  increase at the discretion of the Board.  In
addition,  Mr.  Kasmoch  is eligible for an annual cash bonus in an amount to be
determined,  and  otherwise  subject to the discretion of, the Board.  Under the
agreement, this determination is to be based upon the Board's complete review of
Mr.  Kasmoch's  performance,  including  the  growth  and  profitability  of the
Company.

     Generally,  Mr. Kasmoch's employment agreement may be terminated by us with
or  without  cause  or  by  the  Employee  for  any  reason. If the agreement is
terminated  by us without cause (other than by reason of the death or disability
of  Mr.  Kasmoch),  Mr. Kasmoch will continue to receive his base salary then in
effect  for  the  period between the termination date and the expiration date of
the  agreement.  If  the  agreement is terminated for any other reason by either
party,  Mr. Kasmoch is entitled to receive his base salary through the effective
date  of the termination plus any bonus or incentive compensation which has been
earned  or  payable  through  the  termination  date,  as  provided  for  in the
agreement.  A  copy of Mr. Kasmoch's employment agreement was attached to a Form
8-K  as  Exhibit  10.1,  filed  by  us  on  March  12,  2007.

     Effective  April  2,  2008,  we  entered  into  a  first  amendment  to the
employment  agreement  with  Mr.  Kasmoch. The amendment extends the term of Mr.
Kasmoch's  employment  agreement  for  an additional two years. As a result, the
term  of  Mr.  Kasmoch's  employment agreement will expire on February 12, 2011,
instead  of  February  12,  2009  as  provided  for  in  the original employment
agreement.  Except for the extension of the term, there were no other changes to
Mr.  Kasmoch's  employment agreement. The amendment was approved by our Board of
Directors at a regular meeting held on April 2, 2008. A copy of the amendment to
Mr.  Kasmoch's  employment agreement was attached to a Form 8-K as Exhibit 10.1,
filed  by  us  on  April  7,  2008.

     In  June 2007, we executed an employment agreement with Robert W. Bohmer as
our  Vice-President of Business Development and General Counsel, which commenced
July 1, 2007. Mr. Bohmer's agreement is for a two-year term at $150,000 per year
plus a stock option grant of 100,000 shares. In addition, Mr. Bohmer is eligible
for an annual cash bonus in an amount to be determined. Generally, the agreement
may be terminated by us with or without cause or by the Employee for any reason.
A  copy  of  Mr.  Bohmer's  employment  agreement  was attached to a Form 8-K as
Exhibit  10.1,  filed  by  us  on  June  20,  2007.

     Effective  June  19,  2008,  we  entered  into  a  first  amendment  to the
employment  agreement  with  Mr.  Bohmer.  The amendment extends the term of Mr.
Bohmer's employment agreement for an additional two years. As a result, the term
of  Mr.  Bohmer's  employment  agreement will expire on July 1, 2011, instead of
July  1,  2009  as provided for in the original employment agreement. Except for
the  extension  of  the  term,  there  were  no  other  changes  to Mr. Bohmer's
employment  agreement. The amendment was approved by our Board of Directors at a
regular  meeting  held on June 16, 2008. A copy of the amendment to Mr. Bohmer's
employment  agreement was attached to a Form 8-K as Exhibit 10.1, filed by us on
June  20,  2008.


EQUITY  COMPENSATION  PLAN  INFORMATION

     We  maintain  two  stock option plans for directors, executive officers and
key  employees.  The  current plan was approved by the stockholders in May 2004,
and  amended by the stockholders in June 2008.  The plan, as amended, authorizes
the  Board  of  Directors  or  a committee thereof, to grant awards of incentive
stock  options  and non-qualified stock options for up to a maximum of 1,500,000
shares  of Common Stock.  The total number of options granted and outstanding as
of  June  10,  2009  was 720,925, and the number of options available for future
issuance  was  612,075.  Currently, the plan is administered by the Compensation
Committee.


THE  FOLLOWING  REPORTS  OF  THE  AUDIT COMMITTEE AND THE COMPENSATION COMMITTEE
SHALL NOT BE DEEMED TO BE SOLICITING MATERIAL OR TO BE INCORPORATED BY REFERENCE
IN ANY PREVIOUS OR FUTURE DOCUMENTS FILED BY THE COMPANY WITH THE SECURITIES AND
EXCHANGE  COMMISSION UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES EXCHANGE
ACT  OF  1934, EXCEPT TO THE EXTENT THAT THE COMPANY EXPRESSLY INCORPORATES SAID
REPORTS  BY  REFERENCE  IN  ANY  SUCH  DOCUMENT.




                         COMPENSATION COMMITTEE REPORT

The  following  report was prepared by Thomas L. Kovacik and James H. Hartung as
members  of  our  Compensation  Committee.

     The  compensation  of  our  executive  officers  is  determined  by  the
Compensation  Committee  of  the  Board.

     The Compensation Committee's philosophy is to provide competitive forms and
levels  of  compensation  compared  to  industrial companies of similar size and
business  area.  This  philosophy  is  intended  to  assist  us  in  attracting,
retaining  and  motivating  executives  with  superior leadership and management
abilities.  Consistent  with  this  philosophy,  the  Compensation  Committee
determines a total compensation structure for each officer, consisting primarily
of  salary, bonus and stock options.  The proportions of the various elements of
compensation  vary  among  the  officers  depending  upon  their  levels  of
responsibility.

     The  Compensation Committee establishes salary recommendations to the Board
at  a  level  intended  to be competitive with the average salaries of executive
officers  in comparable companies with adjustments made to reflect our financial
health.  Bonuses  are  intended  to  provide  executives  with an opportunity to
receive  additional  cash  compensation,  but  only  if  they  earn  it  through
individual  performance  and  our  performance.

     Long-term  incentives  are provided through stock options granted under our
Stock  Option  Plan.  The  stock  options  represent  an  additional vehicle for
aligning  management's  and  stockholders'  interest,  specifically  motivating
executives to remain focused on the market value of the Common Stock in addition
to  earnings  per  share  and  return  on  equity  goals.

     The  Compensation Committee, subject to any employment agreements in effect
with  its  executive  officers, reviews and recommends to the Board for approval
the  salaries,  bonuses  and long-term incentives of our officers, including its
most  highly  compensated  executive  officers.  In  addition,  the  Committee
recommends  to  the  Board  the granting of stock options under our Stock Option
Plan  to  executive  officers  and  other  selected  employees, directors and to
consultants,  and  otherwise  administers  our  Stock  Option  Plan.

     With  respect  to compensation of Mr. Timothy R. Kasmoch, our President and
Chief  Executive  Officer,  Mr. Kasmoch's 2008 base salary was determined by his
Employment  Agreement  with us dated February 13, 2007, which entitled him to an
annual  base  salary  of  $150,000  over  a  period  of  two years.  In 2008, an
amendment  dated  April  2,  2008  to this Employment Agreement was agreed upon,
effectively  extending  the  Agreement  until  February  2011.  See  "Employment
Agreements."

     With respect to compensation of Mr. Robert W. Bohmer, our Vice-President of
Business  Development  and  General  Counsel,  Mr. Bohmer's 2008 base salary was
determined  by  his  Employment  Agreement  with  us  dated June 12, 2007, which
entitled  him  to  an annual base salary of $150,000 over a period of two years.
In  2008,  an  amendment  dated  June  19, 2008 to this Employment Agreement was
agreed  upon,  effectively  extending  the  Agreement  until  July  2011.  See
"Employment  Agreements."

     With  respect  to  compensation of Mr. James K. McHugh, our Chief Financial
Officer,  Secretary  and Treasurer, Mr. McHugh's 2008 base salary was determined
by  the  Board of Directors as recommended by the Chief Executive Officer, which
entitled  him to an annual base salary of $100,000, terminable at will by either
party.  At  present  Mr.  McHugh  does not have an employment agreement with the
Company.

     The  Compensation  Committee  is  also  responsible for recommending to the
Board  bonus  amounts,  if  any,  payable  to  Mr.  Kasmoch, the Chief Executive
Officer.  Any  bonuses payable will be determined by the Compensation Committee,
based on the same elements and factors relating to our other Executive Officers.

     The  Compensation  Committee  has  not  formulated  any  policy  regarding
qualifying  compensation  paid to our Executive Officers for deductibility under
the  limits  of Section 162(m) of the Internal Revenue Code of 1986, as amended,
because  the  Compensation  Committee  does  not  anticipate  that any executive
officers  would receive compensation in excess of such limits in the foreseeable
future.

Thomas  L.  Kovacik
James  H.  Hartung


                             AUDIT COMMITTEE REPORT

The  following  report was prepared by Joseph Scheib and Mark Hagans, as members
of  our  Audit  Committee.

     The  Audit  Committee oversees our financial reporting process on behalf of
the  Board.  The  Audit Committee meets with management periodically to consider
the  adequacy  of  our  internal  controls  and the objectivity of our financial
reporting.  The  Audit  Committee  discusses  these matters with our independent
auditors  and  with  appropriate financial personnel and internal auditors.  The
Audit Committee regularly meets privately with both the independent auditors and
the  internal  auditors,  each  of  whom  has  unrestricted  access to the Audit
Committee,  and  recommend  to  the  Board  the  appointment  of the independent
auditors  and  review  periodically  their  performance  and  independence  from
management.  In  addition,  the  Audit Committee reviews our financing plans and
reports  recommendations to the full Board for approval and to authorize action.

     Management  has  primary responsibility of our financial statements and the
overall  reporting  process,  including  our  system  of internal controls.  The
independent  auditors  audit  the  annual  financial  statements  prepared  by
management,  express  an opinion as to whether those financial statements fairly
present  our  financial  position,  results  of  operations  and  cash  flows in
conformity  with  generally  accepted accounting principles and discuss with the
Audit  Committee  any  issues  they  believe  should  be  raised.

     This  year,  the  Audit Committee reviewed our audited financial statements
and  met  with both management and UHY LLP, our independent auditors, to discuss
those financial statements.  Management has represented to us that the financial
statements  were  prepared  in  accordance  with  generally  accepted accounting
principles.

     The  Audit  Committee  has  received  from  and discussed with UHY LLP, the
written  disclosure  and  the  letter  required  by Independence Standards Board
Standard  No.  1  (Independence Discussions with Audit Committees).  These items
related to that firm's independence from us.  The Audit Committee also discussed
with  UHY  LLP,  any  matters  required to be discussed by Statement on Auditing
Standards  No.  61  (Communication  with  Audit  Committees).

     Based  on these reviews and discussions, the Audit Committee recommended to
the  Board  that  the  Company's audited financial statements be included in the
Company's  Annual  Report  on  Form  10-K  for the year ended December 31, 2008.

     Joseph H. Scheib
     Mark D. Hagans


                              INDEPENDENT AUDITORS

APPOINTMENT  OF  UHY  LLP

     The  firm  of  UHY LLP ("UHY") acts as our principal independent registered
public  accounting firm.  Through and as of March 31, 2009, UHY had a continuing
relationship  with UHY Advisors, Inc. ("Advisors") from which it leased auditing
staff  who  were  full  time,  permanent employees of Advisors and through which
UHY's  partners  provide  non-audit  services.  UHY  has  only  a  few full-time
employees.  Therefore, few, if any of the audit services performed were provided
by  permanent, full-time employees of UHY.  UHY manages and supervises the audit
services  and  audit  staff,  and  is  exclusively  responsible  for the opinion
rendered  in  connection  with  its  examination.

     UHY  served  as our principal independent registered public accounting firm
for  the years ended December 31, 2004 through 2008, and has been selected by us
to serve as our independent auditors for the year ending December 31, 2009.  UHY
was  approved  as  our  independent  auditors  by the Board on October 19, 2004.

AUDIT  FEES

     Audit  services  of  UHY  LLP  ("UHY")  included  the  audit  of our annual
financial  statements  for  2008  and  2007,  and  services related to quarterly
filings  with the SEC through the reporting period ended September 30 in each of
those years.  Fees for these services totaled approximately $67,000 for 2008 and
$58,000  for  2007.

AUDIT  RELATED  FEES

     There  were  no  fees  billed  for  the  years  ended December 31, 2008 and
December  31, 2007 for assurance and related services by UHY that are reasonably
related  to  the performance of the audit or review of our financial statements.

TAX  FEES

     There  were  no  fees  billed  for  the  years  ended December 31, 2008 and
December  31, 2007 for professional services rendered by UHY for tax compliance,
tax  advice,  and  tax  planning.

ALL  OTHER  FEES

     UHY provided assistance on accounting related matters totaling $-0- for the
year  ended  December  31, 2008 and $9,000 for the year ended December 31, 2007.

     Although  the  Audit  Committee Charter does not explicitly require it, the
Audit  Committee approves all engagements of outside auditors before any work is
begun  on  the  engagement.


              CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

     None


            SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

     Section  16(a) of the Securities Exchange Act of 1934, as amended, requires
our directors and executive officers, and persons who own beneficially more than
ten  percent  (10%)  of  the  shares  of  our  Common  Stock, to file reports of
ownership  and changes of ownership with the Securities and Exchange Commission,
or SEC.  Copies of all filed reports are required to be furnished to us pursuant
to  Section  16(a).  Based  solely  on the reports received by us and on written
representations  from  reporting  persons, we believe that the current directors
and  executive  officers complied with all applicable filing requirements during
the  fiscal  year  ended  December  31,  2007,  with  the  following exceptions:

          R.  Francis  DiPrete was late filing the following Form 4's (Statement
     of Changes of Beneficial Ownership of Securities) during 2008: (i) a Form 4
     was  filed  on  August  4, 2008, reporting late one sale of Common Stock on
     July  31,  2008,  (ii) a Form 4 was filed on August 6, 2008, reporting late
     two  sales of Common Stock on July 31, 2008 and one sale of Common Stock on
     August  1,  2008, (iii) a Form 4 was filed on September 17, 2008, reporting
     late  one  sale  of  Common  Stock  on  September  12,  2008.

          Timothy  R.  Kasmoch  was  late  filing  a  Form 4 on January 5, 2009,
     reporting  late  one  purchase  of  Common  Stock  on  December  30,  2008.


                STOCKHOLDERS' PROPOSALS FOR NEXT ANNUAL MEETING

     Pursuant  to  Rule  14a-8  under  the  Securities Exchange Act of 1934, any
stockholder  wishing  to  have  a proposal considered for inclusion in our proxy
solicitation  material for the Annual Meeting of Stockholders to be held in 2009
must  set forth such proposal in writing and file it with James K. McHugh, Chief
Financial  Officer,  Treasurer  and Corporate Secretary of the Company, no later
than  March  12, 2010, the date that is less than 120 days before July 10, 2010.
Further,  pursuant  to  Rule  14a-4,  if  a  stockholder fails to notify us of a
proposal before May 26, 2010, the date that is less than 45 days before July 10,
2009 (the approximate mailing date of this proxy statement), such notice will be
considered  untimely  and  management proxies may use their discretionary voting
authority  to  vote  on  any  such  proposal.


                         BY  THE  ORDER  OF  THE  BOARD  OF
                         DIRECTORS

                         /s/  James  K.  McHugh
                         ----------------------
                         James  K.  McHugh
                         Chief  Financial  Officer,  Secretary  and  Treasurer



                                                                      Appendix A

                        N-VIRO INTERNATIONAL CORPORATION
               SECOND AMENDED AND RESTATED2004 STOCK OPTION PLAN
               -------------------------------------------------

     WHEREAS,  the  N-Viro  International Corporation 2004 Stock Option Plan was
originally  adopted  and  approved  in  the  year  2004.

WHEREAS, the N-Viro International Corporation 2004 Stock Option Plan was amended
and  approved  in  the  year  2008.

WHEREAS, the Stockholders of N-Viro International Corporation agree to amend and
restate  the Plan a second time to reflect the increase in the maximum number of
shares  of  Common Stock that may be issued or transferred or exercised pursuant
to  ISOs  under  the  Plan.

NOW,  THEREFORE, BE IT RESOLVED, that the Plan is hereby amended and restated as
follows:

I.     PURPOSE.
       -------

          The purpose of this N-Viro International Corporation 2004 Stock Option
Plan  is  to  enable  N-Viro  International  Corporation  (the "Corporation") to
attract  and  retain  qualified  officers,  other key employees and non-employee
directors,  and  to  provide  an  incentive for such officers, key employers and
directors of the Corporation to expand and improve the profits and prosperity of
the  Corporation.

          The  original  2004  Stock  Option  Plan  was approved by the Board of
Directors  on  February  12,  2004, and by the Corporation's stockholders at the
Annual  Meeting of Stockholders held on May 12, 2004.  This Amended and Restated
2004  Stock Option Plan was approved by the Board of Directors on April 2, 2008,
and  is  being  submitted  for approval by the Corporation's stockholders at the
Annual  Meeting  of  Stockholders  scheduled  for  June  17,  2008.

          The  Amended  and  Restated 2004 Stock Option Plan was approved by the
Board  of  Directors  on April 2, 2008, and by the Corporation's stockholders at
the  Annual  Meeting of Stockholders held on June 17, 2008.  This Second Amended
and  Restated  2004  Stock Option Plan was approved by the Board of Directors on
May  18,  2009,  and  is  being  submitted  for  approval  by  the Corporation's
stockholders at the Annual Meeting of Stockholders scheduled for August 5, 2009.

II.     DEFINITIONS.
        -----------

          The  following  terms  shall  have  the  meanings  shown:

     2.1     "Administrator"  shall mean the Board of Directors or, if the Board
of  Directors has delegated its authority to administer this Plan to a committee
pursuant  to  Article  VIII  hereof,  the  Committee.

     2.2     "Board  of  Directors"  shall  mean  the  Board of Directors of the
Corporation.

     2.3     "Code"  shall  mean  the Internal Revenue Code of 1986, as the same
shall  be  amended  from  time  to  time.

     2.4     "Committee"  shall  mean the Compensation Committee of the Board of
Directors,  or  such other Committee as the Board may appoint to administer this
Plan.  Grants  to  Named  Executive  Officers shall be approved by the Committee
only  if all members of the Committee are directors who qualify as "non-employee
directors"  of  the Corporation within the meaning of Rule 16b-3 and as "outside
directors"  within  the  meaning  of  Treasury  Regulation  1.162-27(e)(3).

     2.5     "Common  Stock"  shall  mean  the  common stock, par value $.01 per
share,  of  the  Corporation,  except  as  provided  in Section 6.2 of the Plan.

     2.6     "Consultant"  shall mean any individual engaged to perform services
for  the  Corporation or any of its Subsidiaries on a regular and on-going basis
who  is  not  a  common  law  employee  of  the  Corporation.

     2.7     "Date  of Grant" shall mean the date specified by the Administrator
on which a grant of Options shall become effective.  The Date of Grant shall not
be  earlier  than  the date on which the Administrator takes action with respect
thereto.

     2.8     "Employee" means any person performing services for the Corporation
or  any  Subsidiary  as  a  common  law employee.  The Administrator may, in its
discretion,  treat  any individual as an Employee for purposes of this Plan even
if  he  or  she  is  not employed by the Corporation, as long as he or she could
properly  be  classified  as  a  common  law  employee  of  the Corporation or a
Subsidiary  for  payroll  tax  purposes.

     2.9     "Fair  Market Value" shall mean the fair market value of a share of
Common Stock of the Corporation as determined by the Administrator.  For periods
when  the Common Stock is publicly traded, this shall be determined by reference
to  the  average  closing  price  for the Common Stock, as reported on any stock
exchange or electronic quotation system on which the Common Stock is then traded
or  quoted, for the previous ten (10) trading days on which trades or quotations
have  been  reported  ending on the trading day immediately preceding the day of
determination  of  the  Fair  Market  Value.  For periods in which fewer than 10
trades  or  quotations have been reported for the 30 calendar days preceding the
day  of  determination  of  the  Fair Market Value, the Fair Market Value may be
determined  by reference to an average of the closing or trading prices reported
during  the prior month or in such other manner as the Administrator may deem to
be  an  appropriate  method of estimating the current market value of the Common
Stock  as  permitted  under  Code.

     2.10     "ISOs"  shall  mean stock options granted by the Corporation which
are  intended  to  qualify  as  incentive stock options under Section 422 of the
Code.

     2.11     "Named  Executive  Officer"  shall  mean  the  Corporation's Chief
Executive  Officer  and  the  four  highest compensated officers (other than the
Chief  Executive  Officer), as determined pursuant to the executive compensation
disclosure rules of Item 402 of Regulation S-K under the Securities Exchange Act
of  1934.

     2.12     "Nonemployee  Director"  shall  mean  a  member  of  the  Board of
Directors  who  is  not  an  employee  or  Consultant  of the Corporation or any
Subsidiary.

     2.13     "Nonstatutory  Options"  shall  mean  stock  options which are not
intended  to  qualify  as  ISOs.

     2.14     "Option  Agreement"  shall  mean  a  written agreement between the
Corporation  and  a  Participant  who  has been granted Options under this Plan.

     2.15     "Option  Price" shall mean, with respect to any Option, the amount
designated  in a Participant's Option Agreement as the price per share he or she
will be required to pay to exercise the Option and acquire the shares subject to
such  Option.  Except  as  otherwise  provided  in Section 3.3, the Option Price
shall  not  be less than 100% of the Fair Market Value of Common Stock as of the
Date  of  Grant.

     2.16     "Options" shall mean any rights to purchase shares of Common Stock
granted  pursuant  to  Article  IV  of  this  Plan,  including  both  ISOs  and
Nonstatutory  Options.

     2.17     "Participant"  shall  mean  any  current  or  former  employee,
Consultant  or  director of the Corporation or a Subsidiary who has been granted
Options  under  the  terms  of  this  Plan.

     2.18     "Plan"  shall  mean  this N-Viro International Corporation Amended
and  Restated  2004  Stock  Option Plan, as the same may be amended from time to
time.

     2.19     "Rule  16b-3"  shall mean Rule 16b-3 promulgated by the Securities
and Exchange Commission under Section 16 of the Securities Exchange Act of 1934,
as  amended  from  time  to  time.

     2.20     "Subsidiary"  shall  mean  any  corporation  which, on the date of
determination,  qualifies  as  a subsidiary corporation of the Corporation under
Section  425(f)  of  the  Code.

     2.21     "Ten  Percent  Stockholder"  shall mean any Participant who at the
time  an  ISO is granted owns (within the meaning of Section 425(d) of the Code)
more  than  ten  percent  of  the  voting  power  of all classes of stock of the
Corporation.

III.     ELIGIBILITY.
         -----------

     3.1     Key Employees.  The Administrator may grant Options under this Plan
             -------------
to  any  officer  or other key employee of the Corporation or of any Subsidiary.
In  granting  such  Options  and  determining  their  form  and  amount,  the
Administrator  shall give consideration to the functions and responsibilities of
the  individual,  his  or her potential contributions to profitability and sound
growth  of  the  Corporation and such other factors as the Administrator may, in
its  discretion,  deem  relevant.

          The  Administrator may also grant Options to Consultants.  In granting
such  Options  and  determining  their  form and amount, the Administrator shall
consider  the extent of the individual's relationship to the Corporation, his or
her  potential  contributions  to  its  financial success, the potential adverse
accounting  consequences  to  the  Corporation  of  stock  option  grants  to
Consultants, and such other factors as the Administrator may, in its discretion,
deem  to  be  relevant.

     3.2     Named  Executive  Officers.  Notwithstanding  Section 3.1, no Named
             --------------------------
Executive Officer shall be granted Options unless the grant has been approved in
advance  by  the  Compensation  Committee  of  the Board of Directors or another
Committee  satisfying  the  requirements  stated  in  Section  2.4.

     3.3     Directors.  Members  of the Board of Directors who are employees or
             ---------
Consultants  of the Corporation shall be eligible for Options under this Plan on
the same terms as other officers.  Other members of the Board of Directors shall
be  eligible for Options only to the extent specified in this Section 3.3, as it
may  be  amended  from  time  to  time  by  the  Board  of  Directors.

     (a)  Each  Non-Employee  Director  who  attends  at  least  one of the four
regularly  scheduled  meetings of the Board for each year shall automatically be
granted  Nonstatutory  Options to purchase 2,500 shares of Common Stock for each
such  meeting attended during the year.  In addition, each Non-Employee Director
who  attends  a special meeting (i.e., not a regularly scheduled meeting) of the
Board  shall  automatically  be  granted  Nonstatutory Options to purchase 1,250
shares  of Common Stock for each special meeting of the Board attended; provided
that  the maximum number of shares with respect to which a Non-Employee Director
may  be  granted  Options for attending either regular or special Board meetings
during  any  single  calendar  year  shall be limited to 15,000 shares of Common
Stock.  Options  granted to a Non-Employee Director for attending Board meetings
shall  be  granted on the date of the meeting, and the Option Price for all such
Options  shall  be  equal  to  the Fair Market Value of the Common Stock on that
date.  Each  such  Option  shall vest six (6) months after the date of grant and
shall  expire  (if  not  exercised  or  terminated  at  any earlier date) on the
earlier  of  (i) the tenth anniversary of grant  and (ii) the day that is ninety
(90)  days  after the date of termination of the Non-Employee Director's service
as a director of the Corporation, unless such event is due to the death or total
and  permanent  disability  of  such  Non-Employee  Director, in which case such
options  shall  terminate twelve (12) months from the date of termination of the
Non-Employee  Director's  service  as  a director of the Corporation due to such
death  or  total  and  permanent disability.  Notwithstanding the foregoing, for
Options  granted on or after January 1, 2005, the Option Price shall be equal to
100%  of  the  Fair  Market  Value  of  Common  Stock  as  of the Date of Grant.

     (b)  In  addition, each Non-Employee Director who was a member of the Board
of  Directors  at  any  time after May 8, 2003 shall be granted on the date this
Plan  is  approved by the Company's stockholders Nonstatutory Stock Options with
respect  to that number of shares provided in subsection (a) above multiplied by
the  number  of  meetings  of  the Board of Directors such Non-Employee Director
attended  after  May  8,  2003, each at an Option Price equal to the Fair Market
Value  of  the Company's Common Stock on May 12, 2004 or such later date as this
plan is approved by the Company's stockholders.  Each such Option shall vest six
(6)  months after the date of grant and shall expire on the tenth anniversary of
grant  (if not exercised or terminated at any earlier date).  These Nonstatutory
Stock  Options  are  intended  to replace the stock options that would have been
automatically  granted  to  these  Non-Employee Directors under the terms of the
Company's  proposed  Stock Option Plan presented at the 2003 Annual Stockholders
Meeting,  and  each  such  grant  is  expressly  conditioned on the Non-Employee
Director's waiver of any claim to receive stock options under Section 3.3 of the
Company's  1998  Amended  and  Restated  Stock  Option  Plan for attending Board
meetings  held  after  May  8,  2003.

IV.     OPTIONS.
        -------

     4.1     Terms  and  Conditions.  The  Administrator  may,  in  its  sole
             ----------------------
discretion,  from  time  to  time  grant Options to any officer, key employee or
Consultant  of  the Corporation or any one of its Subsidiaries.  The grant of an
Option  to  an  eligible officer, employee or Consultant shall be evidenced by a
written  Option  Agreement  in  substantially  the  form  approved  by  the
Administrator.  Such  Option shall be subject to the following express terms and
conditions  and  to  such  other terms and conditions, not inconsistent with the
terms  of  this Plan, as the Administrator (or, in the case of a Named Executive
Officer,  the  Compensation  Committee)  may  deem  appropriate.

          (a)     Shares  Covered.  The  Administrator shall, in its discretion,
                  ---------------
determine  the  number  of  shares  of Common Stock to be covered by the Options
granted  to  any Participant.  The maximum number of shares of Common Stock with
respect  to which Options may be granted to any employee during any one calendar
year  is  25,000  shares.

          (b)     Exercise  Period.  The  term  of each Option shall be for such
                  ----------------
period  as the Administrator shall determine (except as specifically provided in
Section  3.3  above),  but  for  not  more than ten years from the Date of Grant
thereof.  The  Administrator  shall  also  have the discretion to determine when
each  Option  granted  hereunder  shall become exercisable, and to prescribe any
vesting  schedule  limiting  the  exercisability  of such Options as it may deem
appropriate.  The  Administrator  shall  have  the  discretion to prescribe such
vesting  schedules  based  on achievement of corporate or individual performance
targets as it may deem to be appropriate, in addition to vesting schedules based
upon periods of continued employment.  If no other vesting schedule is specified
by  the  Administrator  or  provided  pursuant  to Section 3.3 above, a grant of
Options shall vest and become exercisable in five (5) equal annual installments,
with  successive  installments  vesting, on the Date of Grant and the first four
anniversaries  of  the  Date  of  Grant.

          (c)     Option  Price.  The  Option  Price  payable  for the shares of
                  -------------
Common  Stock covered by any Option shall be determined by the Administrator but
shall  in no event be less than the Fair Market Value of a share of Common Stock
on  the  Date  of  Grant (except as specifically provided in Section 3.3 above).

          (d)     Exercise  of  Options.  A  Participant may exercise his or her
                  ---------------------
Options  from  time  to  time by written notice to the Corporation of his or her
intent  to  exercise  the  Options with respect to a specified number of shares.
The specified number of shares will be issued and transferred to the Participant
upon  receipt by the Corporation of (i) such notice and (ii) payment in full for
such  shares,  and  (iii)  receipt  of  any  payments  required  to  satisfy the
Corporation's  tax  withholding  obligations  pursuant  to  Article  V.

          (e)     Payment  of Option Price Upon Exercise.  Each Option Agreement
                  --------------------------------------
shall  provide  that  the  Option  Price for the shares with respect to which an
Option  is  exercised  shall be paid to the Corporation at the time of exercise.
This  payment generally must be made in the form of cash.  Alternatively, if the
Participant  owns  fewer  than  the  lesser  of  either (i) 50,000 shares of the
Corporation's  Common  Stock,  or  (ii)  one  percent  (1%)  of  the  issued and
outstanding  shares of Common Stock of the Corporation calculated as of the date
of  exercise  (the  "Amount  Held",  and,  for  purposes  of this paragraph, the
calculation  of the Participant's Amount Held shall include all vested Options),
the  Corporation  may  accept  as  payment  of  the  Option  Price:

     (1)     delivery of stock certificates for whole shares of Common Stock
already owned by the Participant for at least six months (at the time of
exercise), valued at their Fair Market Value on the business day immediately
preceding the date of exercise;

     (2)     delivery  of  a signed, irrevocable notice of exercise, accompanied
by  payment  in full of the Option Price by the Participant's stockbroker and an
irrevocable instruction to the Corporation to deliver the shares of Common Stock
issuable  upon  exercise of the Option promptly to the Participant's stockbroker
for  the  Participant's  account;

     (3)     an instruction to withhold as payment of the Option Price a portion
of the shares of Common Stock issuable under the Option with a Fair Market Value
(valued as of the business day immediately preceding the date of exercise) equal
to  the  Option  Price  (provided that the amount paid in cash shall not be less
than  the  par  value  of  the  shares  issuable  upon  such  exercise);  or

     (4)     any  combination  of  the  above  methods equal to the total Option
Price  for  the  shares;

provided  that, the Corporation may refuse to accept any such alternative method
of  payment  of  the Option Price to the extent it determines in good faith that
such  method  of  exercise  would violate the federal securities laws, including
Rule  16b-3,  Section  402  of the Sarbanes-Oxley Act or rules regulating margin
loans.

     4.2     Effect  of  Termination  of  Employment,  Retirement, Disability or
             -------------------------------------------------------------------
Death.
------

          (a)     If  a  Participant's employment (or other relationship, in the
case  of  a  Consultant  or  Director)  with  the  Corporation  is involuntarily
terminated,  or  is  terminated  by  the  Participant  without the Corporation's
express  consent, for any reason other than retirement, disability or death, his
or  her  unvested  Options  shall  terminate upon the date of the termination of
employment,  unless  the Administrator decides, in its sole discretion, to waive
this termination and causes the Participant's Option Agreement to provide for an
extended  exercise  period  after  such  termination.

          (b)     Any  Option  Agreement  may  include  such  provisions  as the
Administrator  deems  advisable  with  respect  to  the  Participant's  right to
exercise  his  or  her  vested  Options subsequent to termination of employment,
provided  that if the Participant's Option Agreement contains no other provision
on  this  point,  the  Participant's  right to exercise the vested Options shall
terminate  ninety  (90)  days after the date of termination of the Participant's
employment.  No  ISO shall be exercisable at any time more than ninety (90) days
after  the  date  of  termination  of  employment, except as provided in Section
4.2(c)  or  (d).

          (c)     Option  Agreements  may  provide  for  an  extended  period of
continued  exercisability  following  the  Participant's  retirement  or  other
termination with the consent of the Corporation, or subsequent to termination of
the Participant's employment by reason of total and permanent disability (within
the  meaning of Section 22(e)(3) of the Code); provided, that, in no event shall
                                               --------
any  Option  be  exercisable  after  the fixed termination date set forth in the
Participant's  Option  Agreement  pursuant  to  Section 4.1(b).  No ISO shall be
exercisable  at  any  time subsequent to the expiration of the period of  ninety
(90)  days  from  the date of termination of employment, or the period of twelve
(12)  months  from  the  date of termination of the Participant's employment (or
other  relationship  with  the  Corporation)  by  reason  of total and permanent
disability, as the case may be.  A termination of employment shall be considered
retirement  if  the  Participant  has  reached  normal  retirement age under the
Corporation's  retirement  plan,  or  as  otherwise  mutually  agreed  by  the
Participant  and  the  Administrator.

          (d)     Any  Option  Agreement  may,  in  the  Administrator's  sole
discretion,  provide that, in the event the Participant dies while in the employ
of  the  Corporation  (or while serving as an active Consultant), or while he or
she  has  the  right to exercise his or her Options under the preceding Sections
4.2(b)  or  (c),  the  Options  may  be  exercised  (to the extent it had become
exercisable prior to the time of the Participant's death), during such period of
up  to one year after date of the Participant's death as the Administrator deems
to  be  appropriate, by the personal representative of the Participant's estate,
or  by  the person or persons to whom the Options shall have been transferred by
will  or  by  the  laws  of  descent  and  distribution.

          (e)     For  purposes  of this Section 4.2, a Participant's employment
with  the Corporation shall be considered to terminate on the last day for which
the  Participant  is  paid  through  the  Corporation's  payroll,  unless  the
Administrator  expressly determines that another date should be used as the date
of  termination  of  employment.  The  Administrator shall determine the date of
termination of any Participant, based on its judgment as to when the Participant
is  no longer employed as a common law employee or Consultant of the Corporation
or any Subsidiary.  Part-time or non-exclusive employment by the Corporation may
be  considered  employment  by  the  Corporation  as  long as the Participant is
treated  as  an  Employee  for  purposes  of  FICA  and  payroll taxes, as shall
employment  by  a  Subsidiary.  In  addition,  the Administrator shall have full
discretion  to  determine whether a Participant's reduction in hours, medical or
disability  leave,  FMLA  leave,  absence  on military or government service, or
other  authorized leave of absence, shall constitute a termination of employment
for purposes of this Plan.  Any such determination of the Administrator shall be
final  and  conclusive,  unless  overruled  by  the  Board  of  Directors.

     4.3     Designation  of  Options  as  Incentive  Stock  Options.  The
             -------------------------------------------------------
Administrator  may,  in  its  discretion,  specify that any Options granted to a
Participant  who  is  an  employee of the Corporation or any Subsidiary shall be
ISOs  qualifying  under  Code Section 422.  Each Option Agreement which provides
for  the grant of ISOs shall designate that such Options are intended to qualify
as ISOs.  Each provision of the Plan and of each Option Agreement relating to an
Option  designated as an ISO shall be construed so that such Option qualifies as
an  ISO,  and  any  provision  that cannot be so construed shall be disregarded.
Options  not  otherwise  designated  shall  be  Nonstatutory  Options.

          Any Options granted under this Plan which are designated as ISOs shall
comply  with  the  following  additional  requirements:

          (a)     The aggregate Fair Market Value (determined at the time an ISO
is  granted) of the shares of Common Stock (together with all other stock of the
Corporation  and all stock of any Subsidiary) with respect to which the ISOs may
first  become exercisable by an individual Participant during any calendar year,
under  all stock option plans of the Corporation (or any Subsidiaries) shall not
exceed $100,000.  To the extent this limitation would otherwise be exceeded, the
Option  shall  be  deemed  to consist of an ISO for the maximum number of shares
which  may  be  covered  by  ISOs  pursuant  to  the  preceding  sentence, and a
Nonstatutory  Option  for  the  remaining  shares  subject  to  the  Option.

          (b)     The Option Price payable upon the exercise of an ISO shall not
be  less  than  the  Fair Market Value of a share of Common Stock on the Date of
Grant;  except  as  otherwise  provided  in  Section  4.3(c)  below.

          (c)     In  the  case  of an ISO granted to a Participant who is a Ten
Percent  Stockholder,  the period of the Option shall not exceed five years from
the  Date  of  Grant, and the Option Price shall not be less than 110 percent of
the  Fair  Market  Value  of  Common  Stock  on  the  Date  of  Grant.

          (d)     The  maximum  term  of any ISO shall be ten years, except that
the  maximum  term of any ISO granted to a Ten Percent Stockholder shall be five
years.

          (e)     No  ISO  granted  under  this  Plan  shall  be  assignable  or
transferable  by  the  Participant, except by will or by the laws of descent and
distribution.  During  the life of the Participant, any ISO shall be exercisable
only  by  the  Participant.

          (f)     Any ISO granted under the Plan shall terminate no more than 90
days after termination of the Participant's employment as an Employee or one (1)
year  after  termination of the Participant's employment as an Employee or after
the  date  of any termination of employment by reason of the Participant's death
or  disability.

          (g)     ISOs  shall  only  be  granted  to  Employees  of the Company.

     4.4     Authority  toMake  Adjustments.     The Administrator may make such
             ------------------------------
adjustments to the terms of such Options as it may deem necessary or appropriate
in  connection  therewith,  including amending the Option Agreement to recognize
that  all  or  a  portion of the Options no longer qualify as ISOs under Section
4.3.

     4.5     Non-Assignability.  Options granted under this Plan shall generally
             -----------------
not  be  assignable or transferable by the Participant, except by will or by the
laws  of  descent  and  distribution,  or  as  described  in the next paragraph.

          Notwithstanding  the  foregoing,  the  Administrator  may,  in  its
discretion,  permit  a  Participant  to  transfer all or a portion of his or her
Options  to members of his or her immediate family, to trusts for the benefit of
members  of his immediate family, or to family partnerships or limited liability
companies in which immediate family members are the only partners, provided that
the  Participant  may receive no consideration for such transfers, and that such
Options  shall  still  be  subject to termination in accordance with Section 4.2
above  in  the  hands  of  the  transferee.

     4.6     Covenants  Not  to  Compete.  The  Administrator  may,  in  its
             ---------------------------
discretion,  condition any Option granted to an Employee, Consultant or director
on  such Participant's agreement to enter into such covenant not to compete with
the  Corporation  as  the Administrator may deem to be desirable.  Such covenant
not to compete shall be set forth in the Participant's Option Agreement, and the
Option  Agreement  shall provide that the Option shall be forfeited immediately,
whether  otherwise  vested  or  not,  if  the  Administrator determines that the
Participant  has  violated  his or her covenant not to compete.  In addition, in
the  Administrator's  discretion,  the  Participant's  Option Agreement may also
provide that if the Participant breaches his or her covenant not to compete, the
Corporation  shall  have  the  right  to  repurchase  any shares of Common Stock
previously issues to the Participant pursuant to an exercise of the Option, at a
repurchase  price  equal  to  the  Option  Price  paid  by  the  Participant.

V.     TAX  WITHHOLDING.
       ----------------

     5.1     Withholding  Taxes.   The  Corporation  shall  have  the  right  to
             ------------------
require  Participants  who  are  employees to remit to the Corporation an amount
sufficient  to satisfy any federal, state and local withholding tax requirements
prior  to  the  delivery  of  any  shares  of Common Stock under the Plan.  If a
Participant  sells, transfers, assigns or otherwise disposes of shares of Common
Stock  acquired  upon the exercise of an ISO within two (2) years after the date
on  which  the  ISO  was granted or within one (1) year after the receipt of the
shares of Common Stock by the Participant, the Participant shall promptly notify
the  Corporation of such disposition and the Corporation shall have the right to
require  the  Participant  to  remit  to the Corporation the amount necessary to
satisfy any federal, state and local tax withholding requirements imposed on the
Corporation  by  reason  of  such  disposition.

     5.2     Methods  of Withholding.  Amounts which the Corporation is entitled
             -----------------------
to withhold pursuant to Section 5.1, may, at the election of the Participant and
with  the approval of the Administrator, be (i) paid in cash by the Participant,
(ii) withheld from the Participant's salary or other compensation payable by the
Corporation,  or  (iii) withheld in the form of shares of Common Stock otherwise
issuable  to  the Participant upon exercise of an Option that have a Fair Market
Value  on  the date on which the amount of tax to be withheld is determined (the
"Tax  Date") not less than the minimum amount of tax the Corporation is required
to  withhold,  or  (iv)  paid  by  means  of  the  Participant's delivery to the
Corporation  of shares of Common Stock already held by the Participant that have
a  Fair  Market Value on the Tax Date not greater than the minimum amount of tax
the  Corporation  is  required  to  withhold,  or (v) in any other form mutually
satisfactory  to  the  Administrator and the Participant, provided that any such
method  of  satisfying the Participant's obligation does not violate any federal
or  state law, including Section 402 of the Sarbanes-Oxley Act.  A Participant's
election  to  have  shares  of Common Stock withheld that are otherwise issuable
shall  be  in  writing, shall be irrevocable upon approval by the Administrator,
and  shall be delivered to the Corporation prior to the Tax Date with respect to
the  exercise  of  an  Option.

VI.     AGGREGATE  LIMITATION  ON  SHARES  OF  COMMON  STOCK.
        ----------------------------------------------------

     6.1     Number of Shares of Common Stock.  Shares of Common Stock which may
             --------------------------------
be  issued  pursuant  to Options granted under the Plan may be either authorized
and  unissued  shares of Common Stock or of Common Stock held by the Corporation
as  treasury  stock.  The  number  of shares of Common Stock which may be issued
under  this  Plan  shall not exceed a total of 2,500,000 shares of Common Stock,
subject  to  such  adjustments as may be made pursuant to Section 6.2.  Further,
the  Options  granted to all Participants during a single calendar year shall be
limited  so  that  such  Options  shall in no event cover more than a maximum of
200,000  shares  of  Common  Stock  (subject  to such adjustments as may be made
pursuant  to  Section  6.2).

          For  purposes of this Section 6.1, upon the exercise of an Option, the
number  of  shares  of Common Stock available for future issuance under the Plan
shall  be  reduced  by  the number of shares actually issued to the Participant,
exclusive  of  any  shares  withheld  for  payment  of  taxes.

          Any  shares  of Common Stock subject to an Option which for any reason
is  cancelled,  terminates  unexercised  or expires shall again be available for
issuance  under  the  Plan.

     6.2     Adjustments  of  Stock.  The  Administrator  shall  proportionately
             ----------------------
adjust the number of shares of Common Stock which may be issued under this Plan,
the  number  of  shares  of  Common Stock subject to Options theretofore granted
under this Plan and the Option Price of such Options, in the event of any change
or  changes  in the outstanding Common Stock of the Corporation by reason of any
stock  dividend,  recapitalization,  reorganization,  merger,  consolidation,
split-up,  combination  or  any  similar transaction, and make any and all other
adjustments  deemed  appropriate  by  the  Administrator  to prevent substantial
dilution  or  enlargement  of  the  rights  granted  to  any  Participant.

          New option rights may be substituted for the Options granted under the
Plan,  or  the Corporation's duties as to Options outstanding under the Plan may
be  assumed  by  another  corporation  or  by a parent or subsidiary (within the
meaning  of  Section  425  of the Code) of such other corporation, in connection
with  any  merger,  consolidation,  acquisition,  separation,  reorganization,
liquidation  or  like  occurrence  in which the Corporation is involved.  In the
event of such substitution or assumption, the term Common Stock shall thereafter
include the stock of the corporation granting such new option rights or assuming
the  Corporation's  duties  as  to  such  Option.

     6.3     Dissolution  or  Merger.  Upon  dissolution  or  liquidation of the
             ------------------------
Corporation,  or  upon a merger or consolidation in which the Corporation is not
the  surviving  corporation,  all  Options  outstanding  under  the  Plan  shall
terminate;  provided,  however,  that  each  Participant  (and each other person
entitled  under  this  Plan  to  exercise  an  Option)  shall  have  the  right,
immediately  prior  to  such  dissolution  or  liquidation,  or  such  merger or
consolidation,  to  exercise such Participant's Options in whole or in part, but
only  to  the extent that such Options are otherwise exercisable under the terms
of  the  Plan.

VII.     MISCELLANEOUS.
         -------------

     7.1     General  Restriction.  Any  Option granted under this Plan shall be
             --------------------
subject  to  the  requirement  that, if at any time the Board of Directors shall
determine that any registration of the shares of Common Stock, or any consent or
approval  of  any  governmental  body,  or  any  other  agreement or consent, is
necessary as a condition of the granting of an Option, or the issuance of Common
Stock in satisfaction thereof, such Option or Common Stock will not be issued or
delivered  until  such  requirement  is  satisfied in a manner acceptable to the
Administrator.

     7.2     Investment  Representation.  If the Administrator determines that a
             --------------------------
written  representation  is  necessary  in  order  to  secure  an exemption from
registration under the Securities Act of 1933, the Administrator may demand that
the  Participant  deliver  to the Corporation at the time of any exercise of any
Option, any written representation that Administrator determines to be necessary
or  appropriate  for such purpose, including but not limited to a representation
that  the  shares  to  be  issued  are to be acquired for investment and not for
resale  or  with a view to the distribution thereof.  If the Administrator makes
such  a  demand,  delivery  of  a  written  representation  satisfactory  to the
Administrator  shall be a condition precedent to the right of the Participant to
acquire  such  shares  of  Common  Stock.

     7.3     No  Right  to Employment.  Nothing in this Plan or in any agreement
             ------------------------
entered  into  pursuant  to  it shall confer upon any participating employee the
right to continue in the employment of the Corporation or affect any right which
the  Corporation  may  have  to  terminate  the employment of such participating
employee.

     7.4     Non-Uniform  Determinations.  The  Administrator's  determinations
             ---------------------------
under  this  Plan  (including,  without  limitation,  its  determinations of the
persons  to  receive Options, the form, amount and timing of such awards and the
terms  and  provisions of such awards) need not be uniform and may be made by it
selectively  among  Participants who receive, or are eligible to receive, awards
under  this  Plan,  whether  or  not  such  Participants are similarly situated.

     7.5     No Rights as Stockholders.  Participants granted Options under this
             -------------------------
Plan  shall have no rights as stockholders of the Corporation as applicable with
respect  thereto  unless  and  until certificates for shares of Common Stock are
issued  to  them.

     7.6     Transfer  Restrictions.  The Administrator's may determine that any
             ----------------------
Common  Stock to be issued by the Corporation upon the exercise of Options shall
be  subject  to  such  further  restrictions  upon transfer as the Administrator
determines  to  be  appropriate.

     7.7     Fractional  Shares.  The Corporation shall not be required to issue
             ------------------
any  fractional  Common  Shares  pursuant  to  this Plan.  The Administrator may
provide  for the elimination of fractions or for the settlement thereof in cash.

VIII.     ADMINISTRATION.
          --------------

          (a)     The  Plan  shall  be  administered  by  the Board of Directors
unless  the  Board has delegated its authority to a Committee consisting of such
members  as  may  be  appointed  by  the  Board  of Directors from time to time.
Notwithstanding  the preceding sentence, the Board of Directors may delegate its
authority  with  respect  to  Named  Executive Officers only to the Compensation
Committee.  With  respect  to  other  Participants, the members of the Committee
need  not  be members of the Board of Directors, and shall serve at the pleasure
of  the  Board  of  Directors.

          (b)     Except  as  provided  in Section 3.2, the Committee shall have
the authority, in its sole discretion, from time to time:  (i) to grant Options,
to  officers,  key employees, and Consultants of the Company, as provided for in
this  Plan; (ii) to prescribe such limitations, restrictions and conditions upon
any  such awards as the Committee shall deem appropriate; (iii) to determine the
periods  during  which Options may be exercised as it may deem appropriate; (iv)
to modify, cancel, or replace any prior Options and to amend the relevant Option
Agreements  with  the  consent  of the affected Participants, including amending
such  agreements to amend vesting schedules, extend exercise periods or increase
or  decrease  the  Option Price for Options, as it may deem to be necessary; and
(v)  to  interpret  the  Plan, to adopt, amend and rescind rules and regulations
relating to the Plan, and to make all other determinations and to take all other
action  necessary or advisable for the imple-mentation and administration of the
Plan.  With  respect  to  any  Named  Executive Officer, this authority shall be
transferred  to  the Compensation Committee, or may be exercised by the Board of
Directors subject to the condition that the express approval of the Compensation
Committee  must  be  obtained.

          (c)     All actions taken by the Board of Directors or Committee shall
be  final,  conclusive and binding upon any eligible employee.  No member of the
Board of Directors or Committee shall be liable for any action taken or decision
made  in  good  faith  relating  to  the  Plan  or  any  award  thereunder.

          (d)     Each member of the Committee shall be entitled, in good faith,
to  rely  or act upon any report or other information furnished to him or her by
any  officer  or  other  employee  of  the  Corporation  or  any Subsidiary, the
Corporation's  independent  certified  public  accountants,  or  any  executive
compensation  consultant,  counsel,  or  other  professional  retained  by  the
Corporation to assist in the administration of the Plan.  No member of the Board
of  Directors  or  the Committee shall be liable for any action or determination
made  by  him  or  her  in  good  faith.

IX.     AMENDMENT  AND  TERMINATION.
        ---------------------------

     9.1     Amendment  or  Termination of the Plan.  The Board of Directors may
             --------------------------------------
at  any  time  terminate this Plan or any part thereof and may from time to time
amend  this  Plan  as  it  may  deem  advisable;  provided, however the Board of
Directors  shall  obtain  stockholder  approval  of  any  amendment  for  which
stockholder  approval  is  required  under  Section  422  of  the  Code,  or the
stockholder  approval  requirements  imposed  on  the Corporation by the listing
rules  of  any  stock  exchange  on  which  the  Common  Stock  is  listed.  The
termination  or  amendment  of  this  Plan shall not, without the consent of the
Participant, affect such Participant's rights under an award previously granted.

     9.2     Term  of  Plan.  Unless  previously  terminated pursuant to Section
             --------------
9.1,  the  Plan  shall terminate on the tenth anniversary of the Plan's original
effective  date,  and  no  Options  may  be  granted  on  or  after  such  date.




                                                                      Appendix B

                            CERTIFICATE OF AMENDMENT
                                       OF
                                   AMENDMENT
                                       TO
                          SECOND AMENDED AND RESTATED
                          CERTIFICATE OF INCORPORATION
                                       OF
                        N-VIRO INTERNATIONAL CORPORATION

                            (a Delaware corporation)

     N-Viro  International  Corporation,  a  Delaware  corporation  (the
"Corporation"),  does  hereby  certify:

     First:   The  original  name  of  the  Corporation  is N-Viro International
Corporation.

     Second:  The  date  on  which  the  Corporation's  original  Certificate of
Incorporation  was filed with the Delaware Secretary of State is April 29, 1993.

     Third:   The  Board  of  Directors of the Corporation, acting in accordance
with  Sections  141(f)  and  242  of the General Corporation Law of the State of
Delaware,  adopted  resolutions  to amend the first paragraph of ARTICLE FOUR of
the  Second Amended and Restated Certificate of Incorporation of the Corporation
to  read  in  its  entirety  as  follows:

          The  total  number of all classes of stock which the Corporation shall
     have  authority  to  issue  is twenty-seven million (27,000,000) shares, of
     which  two million (2,000,000) shares, designated as Preferred Stock, shall
     have  a par value of One Cent ($.01) per share (the "Preferred Stock"), and
     twenty-five  million (25,000,000) shares, designated as Common Stock, shall
     have  a  par  value  of  One  Cent  ($.01)  per share (the "Common Stock").

     Fourth:  Thereafter pursuant to a resolution of the Board of Directors this
Certificate  of  Amendment  was submitted to the stockholders of the Corporation
for  their  approval,  and was duly adopted in accordance with the provisions of
Section  242  of  the  General  Corporation  Law  of  the  State  of  Delaware.

     Fifth:   All  other  provisions  of  the  Second  Amended  and  Restated
Certificate  of  Incorporation  shall  remain  in  full  force  and  effect.

     I,  James  K.  McHugh,  being  the  Chief  Financial Officer, Secretary and
Treasurer  of  the Corporation, do hereby declare and certify that the foregoing
Amendment  to  Second Amended and Restated Certificate of Incorporation was duly
adopted in accordance with DGCL Sections 103, 242 and 245, at the Annual Meeting
of  Stockholders of the Corporation held on          , 2009, and I further state
                                           ----------
that  the  execution of the Amendment to Second Amended and Restated Certificate
of  Incorporation  is  my  own act and deed and that the facts herein stated are
true,  and  accordingly  I  have  hereunto  set  my  hand  this      day  of
                                                                -----        ---
   ,  2009.
---

     By:
         James K. McHugh, Chief Financial Officer,
                Secretary and Treasurer




                                                                      Appendix C

[N-Viro International Corporation logo]
c/o Corporate Election Services
P. O. Box 1150
Pittsburgh, PA  15230

--------------------------------------------------------------------------------
VOTE BY TELEPHONE
--------------------------------------------------------------------------------
Have  your  proxy  card available when you call Toll-Free 1-888-693-8683 using a
touch-tone  phone  and  follow  the  simple  instructions  to  record your vote.


--------------------------------------------------------------------------------
VOTE  BY  INTERNET
--------------------------------------------------------------------------------
Have  your  proxy card available when you access the website www.cesvote.com and
follow  the  simple  instructions  to  record  your  vote.


--------------------------------------------------------------------------------
VOTE  BY  MAIL
--------------------------------------------------------------------------------
Please  mark,  sign  and  date your proxy card and return it in the postage-paid
envelope  provided  or return it to: Corporate Election Services, P.O. Box 1150,
Pittsburgh  PA  15230-1150.


        Vote by Telephone        Vote by Internet            Vote by Mail
     -----------------------   ----------------------    -------------------
     Call Toll-Free using a    Access the Website and     Return your proxy
        touch-tone telephone:     cast your vote:        in the postage-paid
            1-888-693-8683      www.cesvote.com           envelope provided

                       Vote 24 hours a day, 7 days a week!
  If you vote by telephone or internet, please do not send your proxy by mail.

                          [Graphic Omitted]

                   Proxy card must be signed and dated below.
            Please fold and detach card at perforation before mailing.
--------------------------------------------------------------------------------

[N-Viro International Corporation logo]


   THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS FOR THE ANNUAL
             MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 5, 2009.

Revoking  all  prior  proxies,  the  undersigned,  a  stockholder  of  N-VIRO
INTERNATIONAL  CORPORATION  (the  "Company"), hereby appoints Timothy R. Kasmoch
and  James K. McHugh, and each of them, attorneys and agents of the undersigned,
with  full  power  of  substitution  to vote all shares of the Common Stock, par
value  $.01 per share (the "Common Stock"), of the undersigned in the Company at
the  Annual  Meeting  of  Stockholders  of  the Company to be held at Brandywine
Country  Club,  6904  Salisbury  Road, Maumee, Ohio, 43537, on August 5, 2009 at
3:00  p.m., local time, and at any adjournment thereof, as fully and effectively
as  the undersigned could do if personally present and voting, hereby approving,
ratifying and confirming all that said attorneys and agents or their substitutes
may  lawfully  do  in  place of the undersigned as indicated on the reverse.  In
their  discretion,  the  proxies  are  authorized to vote upon any other matters
which  may  properly  come  before  the  meeting  or  any  adjournment  thereof.

Dated:                    ,  2009
      --------------------

--------------------------
Signature

--------------------------
Signature

Please  sign  exactly as your name appears to the left.  When shares are held by
joint  tenants,  both  should  sign.  When  signing  as  attorney,  executor,
administrator,  trustee  or  guardian,  please  give  full  title as such.  If a
corporation,  please  sign  in  the  full corporation name by President or other
authorized  officer.  If  a  partnership,  please  sign  in  partnership name by
authorized  person.



                   PROXY CARD MUST BE SIGNED AND DATED BELOW.
           PLEASE FOLD AND DETACH CARD AT PERFORATION BEFORE MAILING.
--------------------------------------------------------------------------------
--------------------------------------------------
N-VIRO  INTERNATIONAL  CORPORATION
PROXY

THIS  PROXY WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED.  IF NO DIRECTIONS
ARE  INDICATED, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE LISTED NOMINEES
AS  CLASS  I  DIRECTORS  AND  FOR  PROPOSALS  2  THROUGH  4.

1.     To  elect  four  Class  I  directors to serve for a term of two years and
until  their  successors  are  elected  and  qualified:

     Nominees:
     1.     Mark  D. Hagans         FOR              AGAINST      ABSTAIN
     2.     Carl  Richard           FOR              AGAINST      ABSTAIN
     3.     Joseph  Scheib          FOR              AGAINST      ABSTAIN
     4.     Joan  B.  Wills         FOR              AGAINST      ABSTAIN

2.     To  adopt an amendment to our Amended and Restated 2004 Stock Option Plan
to  increase  the  number  of  shares  available  under  the  plan.

      FOR           AGAINST           ABSTAIN

3.     To approve an amendment to our Second Amended and Restated Certificate of
Incorporation  to  increase  the  authorized  shares  of  Common  Stock.

      FOR           AGAINST           ABSTAIN

4.     To ratify the appointment of UHY LLP as independent auditors for the
Company for 2009.

      FOR           AGAINST           ABSTAIN

5.     To transact such other business as may properly come before the meeting
or any adjournment or postponement thereof.

    PLEASE CHECK HERE IF YOU PLAN TO ATTEND THE ANNUAL MEETING

           Continued and to be signed and dated on the reverse side.